JPH10293376A - Silver halide emulsion and photosensitive material using the same - Google Patents
Silver halide emulsion and photosensitive material using the sameInfo
- Publication number
- JPH10293376A JPH10293376A JP3721698A JP3721698A JPH10293376A JP H10293376 A JPH10293376 A JP H10293376A JP 3721698 A JP3721698 A JP 3721698A JP 3721698 A JP3721698 A JP 3721698A JP H10293376 A JPH10293376 A JP H10293376A
- Authority
- JP
- Japan
- Prior art keywords
- silver halide
- emulsion
- silver
- grains
- added
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000839 emulsion Substances 0.000 title claims abstract description 198
- 229910052709 silver Inorganic materials 0.000 title claims abstract description 131
- 239000004332 silver Substances 0.000 title claims abstract description 131
- -1 Silver halide Chemical class 0.000 title claims abstract description 98
- 239000000463 material Substances 0.000 title claims description 24
- 206010070834 Sensitisation Diseases 0.000 claims abstract description 80
- 230000008313 sensitization Effects 0.000 claims abstract description 80
- 150000001875 compounds Chemical class 0.000 claims abstract description 28
- ADZWSOLPGZMUMY-UHFFFAOYSA-M silver bromide Chemical compound [Ag]Br ADZWSOLPGZMUMY-UHFFFAOYSA-M 0.000 claims abstract description 10
- 125000003118 aryl group Chemical group 0.000 claims abstract description 8
- 125000001931 aliphatic group Chemical group 0.000 claims abstract description 7
- 238000004519 manufacturing process Methods 0.000 claims abstract description 6
- 150000001768 cations Chemical class 0.000 claims abstract description 5
- 125000000623 heterocyclic group Chemical group 0.000 claims abstract description 5
- 125000002723 alicyclic group Chemical group 0.000 claims abstract description 4
- 230000009467 reduction Effects 0.000 claims description 60
- 239000002019 doping agent Substances 0.000 claims description 25
- 239000000126 substance Substances 0.000 claims description 22
- 125000005647 linker group Chemical group 0.000 claims description 4
- 229920000642 polymer Polymers 0.000 claims description 4
- 238000000034 method Methods 0.000 abstract description 52
- 230000035945 sensitivity Effects 0.000 abstract description 41
- 230000008569 process Effects 0.000 abstract description 5
- 230000008878 coupling Effects 0.000 abstract 1
- 238000010168 coupling process Methods 0.000 abstract 1
- 238000005859 coupling reaction Methods 0.000 abstract 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 52
- 239000000243 solution Substances 0.000 description 31
- 239000000975 dye Substances 0.000 description 27
- 230000003595 spectral effect Effects 0.000 description 27
- 238000007792 addition Methods 0.000 description 26
- 206010063836 Atrioventricular septal defect Diseases 0.000 description 25
- 238000001211 electron capture detection Methods 0.000 description 25
- 230000001235 sensitizing effect Effects 0.000 description 24
- 230000006911 nucleation Effects 0.000 description 20
- 238000010899 nucleation Methods 0.000 description 20
- 239000010410 layer Substances 0.000 description 19
- 239000002245 particle Substances 0.000 description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 19
- 108010010803 Gelatin Proteins 0.000 description 18
- 229920000159 gelatin Polymers 0.000 description 18
- 239000008273 gelatin Substances 0.000 description 18
- 235000019322 gelatine Nutrition 0.000 description 18
- 235000011852 gelatine desserts Nutrition 0.000 description 18
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 15
- 230000012010 growth Effects 0.000 description 14
- COTCLZIUSPWWJJ-UHFFFAOYSA-M [Na+].[O-]S(=O)=S Chemical compound [Na+].[O-]S(=O)=S COTCLZIUSPWWJJ-UHFFFAOYSA-M 0.000 description 12
- 238000001556 precipitation Methods 0.000 description 12
- RYYXDZDBXNUPOG-UHFFFAOYSA-N 4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine;dihydrochloride Chemical compound Cl.Cl.C1C(N)CCC2=C1SC(N)=N2 RYYXDZDBXNUPOG-UHFFFAOYSA-N 0.000 description 11
- 101710134784 Agnoprotein Proteins 0.000 description 11
- 239000002253 acid Substances 0.000 description 11
- 239000002356 single layer Substances 0.000 description 11
- 150000004820 halides Chemical class 0.000 description 10
- ZUNKMNLKJXRCDM-UHFFFAOYSA-N silver bromoiodide Chemical compound [Ag].IBr ZUNKMNLKJXRCDM-UHFFFAOYSA-N 0.000 description 10
- 229910052717 sulfur Inorganic materials 0.000 description 10
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 9
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 9
- 238000000151 deposition Methods 0.000 description 9
- 235000019580 granularity Nutrition 0.000 description 9
- 230000006872 improvement Effects 0.000 description 9
- 229930182817 methionine Natural products 0.000 description 9
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Substances [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 9
- 239000011593 sulfur Substances 0.000 description 9
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 8
- 230000008021 deposition Effects 0.000 description 8
- 239000003446 ligand Substances 0.000 description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 7
- 230000005070 ripening Effects 0.000 description 7
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 229910052798 chalcogen Inorganic materials 0.000 description 6
- 238000011161 development Methods 0.000 description 6
- 230000018109 developmental process Effects 0.000 description 6
- 238000009826 distribution Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 229910052737 gold Inorganic materials 0.000 description 6
- 239000010931 gold Substances 0.000 description 6
- 239000007800 oxidant agent Substances 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 5
- 210000000988 bone and bone Anatomy 0.000 description 5
- 150000001787 chalcogens Chemical class 0.000 description 5
- 239000011248 coating agent Substances 0.000 description 5
- 238000000576 coating method Methods 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 5
- 229910052751 metal Inorganic materials 0.000 description 5
- 239000002184 metal Substances 0.000 description 5
- 229910021645 metal ion Inorganic materials 0.000 description 5
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 description 5
- PISVIEQBTMLLCS-UHFFFAOYSA-M sodium;ethyl-oxido-oxo-sulfanylidene-$l^{6}-sulfane Chemical compound [Na+].CCS([O-])(=O)=S PISVIEQBTMLLCS-UHFFFAOYSA-M 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- GGZHVNZHFYCSEV-UHFFFAOYSA-N 1-Phenyl-5-mercaptotetrazole Chemical compound SC1=NN=NN1C1=CC=CC=C1 GGZHVNZHFYCSEV-UHFFFAOYSA-N 0.000 description 4
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 4
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 4
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 4
- 229910021607 Silver chloride Inorganic materials 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 125000000217 alkyl group Chemical group 0.000 description 4
- 235000011114 ammonium hydroxide Nutrition 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 239000000460 chlorine Substances 0.000 description 4
- 238000000407 epitaxy Methods 0.000 description 4
- 229910052740 iodine Inorganic materials 0.000 description 4
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 4
- 238000001429 visible spectrum Methods 0.000 description 4
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- 229960000583 acetic acid Drugs 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 150000004696 coordination complex Chemical class 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000000737 periodic effect Effects 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000001179 sorption measurement Methods 0.000 description 3
- 230000000087 stabilizing effect Effects 0.000 description 3
- 125000001424 substituent group Chemical group 0.000 description 3
- AGJZCWVTGOVGBS-UHFFFAOYSA-N 1,1'-diethyl-2,2'-cyanine Chemical compound C1=CC2=CC=CC=C2N(CC)\C1=C\C1=CC=C(C=CC=C2)C2=[N+]1CC AGJZCWVTGOVGBS-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 101150055297 SET1 gene Proteins 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 125000003342 alkenyl group Chemical group 0.000 description 2
- 125000000304 alkynyl group Chemical group 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- XYXNTHIYBIDHGM-UHFFFAOYSA-N ammonium thiosulfate Chemical compound [NH4+].[NH4+].[O-]S([O-])(=O)=S XYXNTHIYBIDHGM-UHFFFAOYSA-N 0.000 description 2
- 230000003698 anagen phase Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000002518 antifoaming agent Substances 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 239000012298 atmosphere Substances 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical compound C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 2
- 238000004061 bleaching Methods 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000000586 desensitisation Methods 0.000 description 2
- 230000002542 deteriorative effect Effects 0.000 description 2
- 238000010893 electron trap Methods 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 150000002334 glycols Chemical class 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- VKYKSIONXSXAKP-UHFFFAOYSA-N hexamethylenetetramine Chemical compound C1N(C2)CN3CN1CN2C3 VKYKSIONXSXAKP-UHFFFAOYSA-N 0.000 description 2
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 229910052741 iridium Inorganic materials 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 125000001624 naphthyl group Chemical group 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 229910000510 noble metal Inorganic materials 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 150000002892 organic cations Chemical class 0.000 description 2
- 239000013110 organic ligand Substances 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 229910052763 palladium Inorganic materials 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 229920000768 polyamine Polymers 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- ZNNZYHKDIALBAK-UHFFFAOYSA-M potassium thiocyanate Chemical compound [K+].[S-]C#N ZNNZYHKDIALBAK-UHFFFAOYSA-M 0.000 description 2
- 229940116357 potassium thiocyanate Drugs 0.000 description 2
- 238000002601 radiography Methods 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 150000003378 silver Chemical class 0.000 description 2
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 2
- 235000019345 sodium thiosulphate Nutrition 0.000 description 2
- BZHOWMPPNDKQSQ-UHFFFAOYSA-M sodium;sulfidosulfonylbenzene Chemical compound [Na+].[O-]S(=O)(=S)C1=CC=CC=C1 BZHOWMPPNDKQSQ-UHFFFAOYSA-M 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- TXUICONDJPYNPY-UHFFFAOYSA-N (1,10,13-trimethyl-3-oxo-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl) heptanoate Chemical compound C1CC2CC(=O)C=C(C)C2(C)C2C1C1CCC(OC(=O)CCCCCC)C1(C)CC2 TXUICONDJPYNPY-UHFFFAOYSA-N 0.000 description 1
- GVEYRUKUJCHJSR-UHFFFAOYSA-N (4-azaniumyl-3-methylphenyl)-ethyl-(2-hydroxyethyl)azanium;sulfate Chemical compound OS(O)(=O)=O.OCCN(CC)C1=CC=C(N)C(C)=C1 GVEYRUKUJCHJSR-UHFFFAOYSA-N 0.000 description 1
- UGUHFDPGDQDVGX-UHFFFAOYSA-N 1,2,3-thiadiazole Chemical group C1=CSN=N1 UGUHFDPGDQDVGX-UHFFFAOYSA-N 0.000 description 1
- AIGNCQCMONAWOL-UHFFFAOYSA-N 1,3-benzoselenazole Chemical compound C1=CC=C2[se]C=NC2=C1 AIGNCQCMONAWOL-UHFFFAOYSA-N 0.000 description 1
- BCMCBBGGLRIHSE-UHFFFAOYSA-N 1,3-benzoxazole Chemical compound C1=CC=C2OC=NC2=C1 BCMCBBGGLRIHSE-UHFFFAOYSA-N 0.000 description 1
- ODIRBFFBCSTPTO-UHFFFAOYSA-N 1,3-selenazole Chemical compound C1=C[se]C=N1 ODIRBFFBCSTPTO-UHFFFAOYSA-N 0.000 description 1
- PYWQACMPJZLKOQ-UHFFFAOYSA-N 1,3-tellurazole Chemical compound [Te]1C=CN=C1 PYWQACMPJZLKOQ-UHFFFAOYSA-N 0.000 description 1
- WUIJTQZXUURFQU-UHFFFAOYSA-N 1-methylsulfonylethene Chemical compound CS(=O)(=O)C=C WUIJTQZXUURFQU-UHFFFAOYSA-N 0.000 description 1
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 1
- IHWDSEPNZDYMNF-UHFFFAOYSA-N 1H-indol-2-amine Chemical compound C1=CC=C2NC(N)=CC2=C1 IHWDSEPNZDYMNF-UHFFFAOYSA-N 0.000 description 1
- KLIDCXVFHGNTTM-UHFFFAOYSA-N 2,6-dimethoxyphenol Chemical compound COC1=CC=CC(OC)=C1O KLIDCXVFHGNTTM-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 1
- NYYSPVRERVXMLJ-UHFFFAOYSA-N 4,4-difluorocyclohexan-1-one Chemical compound FC1(F)CCC(=O)CC1 NYYSPVRERVXMLJ-UHFFFAOYSA-N 0.000 description 1
- ZNBNBTIDJSKEAM-UHFFFAOYSA-N 4-[7-hydroxy-2-[5-[5-[6-hydroxy-6-(hydroxymethyl)-3,5-dimethyloxan-2-yl]-3-methyloxolan-2-yl]-5-methyloxolan-2-yl]-2,8-dimethyl-1,10-dioxaspiro[4.5]decan-9-yl]-2-methyl-3-propanoyloxypentanoic acid Chemical compound C1C(O)C(C)C(C(C)C(OC(=O)CC)C(C)C(O)=O)OC11OC(C)(C2OC(C)(CC2)C2C(CC(O2)C2C(CC(C)C(O)(CO)O2)C)C)CC1 ZNBNBTIDJSKEAM-UHFFFAOYSA-N 0.000 description 1
- INVVMIXYILXINW-UHFFFAOYSA-N 5-methyl-1h-[1,2,4]triazolo[1,5-a]pyrimidin-7-one Chemical compound CC1=CC(=O)N2NC=NC2=N1 INVVMIXYILXINW-UHFFFAOYSA-N 0.000 description 1
- 101100365548 Caenorhabditis elegans set-14 gene Proteins 0.000 description 1
- 101100095642 Caenorhabditis elegans set-25 gene Proteins 0.000 description 1
- 101100095643 Caenorhabditis elegans set-26 gene Proteins 0.000 description 1
- 101100042371 Caenorhabditis elegans set-3 gene Proteins 0.000 description 1
- 101100421296 Caenorhabditis elegans set-6 gene Proteins 0.000 description 1
- 101100256732 Caenorhabditis elegans set-9 gene Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- QDHHCQZDFGDHMP-UHFFFAOYSA-N Chloramine Chemical compound ClN QDHHCQZDFGDHMP-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- HBBGRARXTFLTSG-UHFFFAOYSA-N Lithium ion Chemical compound [Li+] HBBGRARXTFLTSG-UHFFFAOYSA-N 0.000 description 1
- 235000011779 Menyanthes trifoliata Nutrition 0.000 description 1
- 240000008821 Menyanthes trifoliata Species 0.000 description 1
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 description 1
- 229910019093 NaOCl Inorganic materials 0.000 description 1
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical group O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 1
- 239000012425 OXONE® Substances 0.000 description 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 1
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 1
- 241000015864 Protobothrops flavoviridis Species 0.000 description 1
- 101150104646 SET4 gene Proteins 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 1
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 1
- 229910052770 Uranium Inorganic materials 0.000 description 1
- XCFIVNQHHFZRNR-UHFFFAOYSA-N [Ag].Cl[IH]Br Chemical compound [Ag].Cl[IH]Br XCFIVNQHHFZRNR-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 125000004442 acylamino group Chemical group 0.000 description 1
- 125000004423 acyloxy group Chemical group 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 125000004450 alkenylene group Chemical group 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000004414 alkyl thio group Chemical group 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 229940100198 alkylating agent Drugs 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- 125000004419 alkynylene group Chemical group 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- SWLVFNYSXGMGBS-UHFFFAOYSA-N ammonium bromide Chemical compound [NH4+].[Br-] SWLVFNYSXGMGBS-UHFFFAOYSA-N 0.000 description 1
- SOIFLUNRINLCBN-UHFFFAOYSA-N ammonium thiocyanate Chemical compound [NH4+].[S-]C#N SOIFLUNRINLCBN-UHFFFAOYSA-N 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 229910052787 antimony Inorganic materials 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- 125000005110 aryl thio group Chemical group 0.000 description 1
- 125000000732 arylene group Chemical group 0.000 description 1
- 125000005200 aryloxy carbonyloxy group Chemical group 0.000 description 1
- 125000004104 aryloxy group Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- KZTASAUPEDXWMQ-UHFFFAOYSA-N azane;iron(3+) Chemical compound N.[Fe+3] KZTASAUPEDXWMQ-UHFFFAOYSA-N 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- DMSMPAJRVJJAGA-UHFFFAOYSA-N benzo[d]isothiazol-3-one Chemical compound C1=CC=C2C(=O)NSC2=C1 DMSMPAJRVJJAGA-UHFFFAOYSA-N 0.000 description 1
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 1
- 239000012964 benzotriazole Substances 0.000 description 1
- 229910052797 bismuth Inorganic materials 0.000 description 1
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 1
- UORVGPXVDQYIDP-BJUDXGSMSA-N borane Chemical class [10BH3] UORVGPXVDQYIDP-BJUDXGSMSA-N 0.000 description 1
- 125000004369 butenyl group Chemical group C(=CCC)* 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000000480 butynyl group Chemical group [*]C#CC([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 229940126214 compound 3 Drugs 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- IBAHLNWTOIHLKE-UHFFFAOYSA-N cyano cyanate Chemical compound N#COC#N IBAHLNWTOIHLKE-UHFFFAOYSA-N 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- YPTUAQWMBNZZRN-UHFFFAOYSA-N dimethylaminoboron Chemical compound [B]N(C)C YPTUAQWMBNZZRN-UHFFFAOYSA-N 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000000635 electron micrograph Methods 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 238000004773 frontier orbital Methods 0.000 description 1
- 229910052733 gallium Inorganic materials 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- 239000004312 hexamethylene tetramine Substances 0.000 description 1
- 235000010299 hexamethylene tetramine Nutrition 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 150000002429 hydrazines Chemical class 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 229910000378 hydroxylammonium sulfate Inorganic materials 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 229910052738 indium Inorganic materials 0.000 description 1
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 229910052745 lead Inorganic materials 0.000 description 1
- 229910001416 lithium ion Inorganic materials 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 150000002736 metal compounds Chemical class 0.000 description 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
- 125000002950 monocyclic group Chemical group 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 125000004957 naphthylene group Chemical group 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 229910052758 niobium Inorganic materials 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229910052762 osmium Inorganic materials 0.000 description 1
- WCPAKWJPBJAGKN-UHFFFAOYSA-N oxadiazole Chemical compound C1=CON=N1 WCPAKWJPBJAGKN-UHFFFAOYSA-N 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 125000004043 oxo group Chemical group O=* 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- QUBQYFYWUJJAAK-UHFFFAOYSA-N oxymethurea Chemical compound OCNC(=O)NCO QUBQYFYWUJJAAK-UHFFFAOYSA-N 0.000 description 1
- 229950005308 oxymethurea Drugs 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- HJKYXKSLRZKNSI-UHFFFAOYSA-I pentapotassium;hydrogen sulfate;oxido sulfate;sulfuric acid Chemical compound [K+].[K+].[K+].[K+].[K+].OS([O-])(=O)=O.[O-]S([O-])(=O)=O.OS(=O)(=O)O[O-].OS(=O)(=O)O[O-] HJKYXKSLRZKNSI-UHFFFAOYSA-I 0.000 description 1
- 229960003330 pentetic acid Drugs 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 description 1
- 125000003356 phenylsulfanyl group Chemical group [*]SC1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 239000004848 polyfunctional curative Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- BHZRJJOHZFYXTO-UHFFFAOYSA-L potassium sulfite Chemical compound [K+].[K+].[O-]S([O-])=O BHZRJJOHZFYXTO-UHFFFAOYSA-L 0.000 description 1
- 235000019252 potassium sulphite Nutrition 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 229910052702 rhenium Inorganic materials 0.000 description 1
- 229910052703 rhodium Inorganic materials 0.000 description 1
- 229910052707 ruthenium Inorganic materials 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229910052706 scandium Inorganic materials 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- CRDYSYOERSZTHZ-UHFFFAOYSA-M selenocyanate Chemical compound [Se-]C#N CRDYSYOERSZTHZ-UHFFFAOYSA-M 0.000 description 1
- 101150004276 set-23 gene Proteins 0.000 description 1
- 150000004756 silanes Chemical class 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- 239000001119 stannous chloride Substances 0.000 description 1
- 235000011150 stannous chloride Nutrition 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- 229910052714 tellurium Inorganic materials 0.000 description 1
- PORWMNRCUJJQNO-UHFFFAOYSA-N tellurium atom Chemical compound [Te] PORWMNRCUJJQNO-UHFFFAOYSA-N 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- DZLFLBLQUQXARW-UHFFFAOYSA-N tetrabutylammonium Chemical compound CCCC[N+](CCCC)(CCCC)CCCC DZLFLBLQUQXARW-UHFFFAOYSA-N 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- QEMXHQIAXOOASZ-UHFFFAOYSA-N tetramethylammonium Chemical compound C[N+](C)(C)C QEMXHQIAXOOASZ-UHFFFAOYSA-N 0.000 description 1
- USFPINLPPFWTJW-UHFFFAOYSA-N tetraphenylphosphonium Chemical compound C1=CC=CC=C1[P+](C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 USFPINLPPFWTJW-UHFFFAOYSA-N 0.000 description 1
- 150000003536 tetrazoles Chemical class 0.000 description 1
- 229910052716 thallium Inorganic materials 0.000 description 1
- 150000003567 thiocyanates Chemical class 0.000 description 1
- 150000003568 thioethers Chemical class 0.000 description 1
- 229930192474 thiophene Natural products 0.000 description 1
- GWIKYPMLNBTJHR-UHFFFAOYSA-M thiosulfonate group Chemical group S(=S)(=O)[O-] GWIKYPMLNBTJHR-UHFFFAOYSA-M 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 150000003606 tin compounds Chemical class 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 150000003852 triazoles Chemical class 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 125000003774 valeryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000004876 x-ray fluorescence Methods 0.000 description 1
- 125000006839 xylylene group Chemical group 0.000 description 1
- 229910052727 yttrium Inorganic materials 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 229910052726 zirconium Inorganic materials 0.000 description 1
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明はハロゲン化銀乳剤及
びそれを用いた写真感光材料に関し、特に高感度でカブ
リの発生が少なく、鮮鋭度が良好なハロゲン化銀乳剤及
びそれを用いた写真感光材料に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a silver halide emulsion and a photographic light-sensitive material using the same, and more particularly to a silver halide emulsion having high sensitivity, low fogging and good sharpness, and a photographic light-sensitive material using the same. About the material.
【0002】[0002]
【従来の技術】米国特許第4,439,520号(Ko
fron等)は、現在の高性能ハロゲン化銀写真時代の
到来を告げた。Kofron等は、粒子直径が少なくと
も0.6μmであり、かつ粒子厚さが0.3μm未満の
平板状ハロゲン化銀粒子(以下、平板状粒子ともいう)
が、平均アスペクト比が8を超え且つ総粒子投影面積の
50%を超える割合を占める化学的増感及び分光増感し
た平板状粒子乳剤に関する注目すべき写真上の利点を開
示し且つ示した。示されている多数の乳剤のうち、これ
らの数値パラメータの一つ以上が、上記要件をはるかに
超えることがよくあった。Kofron等は、種々の態
様の一つ以上に開示されている化学増感及び分光増感乳
剤がカラー写真及び白黒写真(間接放射線写真を含む)
に有用であろうことを認識していた。白黒像形成用途の
ためのオルソクロマチック及びパンクロマチック分光増
感だけでなく、可視スペクトルの全ての部分及びよリ長
波長での分光増感も試みられた。Kofron等は、一
種以上の分光増感色素とミドルカルコゲン(例えば、イ
オウ)及び/若しくは貴金属(例えば、金)化学増感と
の組み合わせを用いた。しかしながら、Kofron等
は、更に他の変性化合物、例えば、金属化合物を析出時
に必要に応じて存在させることや還元増感等の通常の増
感も開示している。2. Description of the Related Art U.S. Pat. No. 4,439,520 (Ko)
fron et al.) signaled the advent of the current high-performance silver halide photographic era. Kofron et al. Have tabular silver halide grains having a grain diameter of at least 0.6 μm and a grain thickness of less than 0.3 μm (hereinafter also referred to as tabular grains).
Disclose and showed remarkable photographic advantages for chemically and spectrally sensitized tabular grain emulsions having an average aspect ratio of greater than 8 and greater than 50% of total grain projected area. Of the numerous emulsions shown, one or more of these numerical parameters often far exceeded the above requirements. Kofron et al. Disclose chemically and spectrally sensitized emulsions disclosed in one or more of various embodiments in color and black and white photography (including indirect radiography).
Knew it would be useful. Spectral sensitization in all parts of the visible spectrum and at longer wavelengths has been attempted, as well as orthochromatic and panchromatic spectral sensitization for black and white imaging applications. Used a combination of one or more spectral sensitizing dyes with middle chalcogen (eg, sulfur) and / or noble metal (eg, gold) chemical sensitization. However, Kofron et al. Also discloses the usual sensitization, such as the presence of other modifying compounds, for example, metal compounds, as required at the time of deposition, and reduction sensitization.
【0003】1982年に、Kofron等の開示を取
り入れた第一間接放射線写真及びカラー写真フィルムが
商業的に導入された。15年後の現在、考えられる製品
の種類に応じて異なる平板状粒子乳剤が好ましいことが
明瞭に理解されている。間接放射線写真は、超薄平板状
粒子乳剤が好ましくない温調(即ち、褐色がかった黒
色)画像色調を有する銀を生じるので魅力的でないこと
が分かった。カメラスピードカラー写真フィルムにおい
て、超薄平板状粒子乳剤は、通常魅力的であり、特に固
有粒子感度が低い波長領域、例えば、約430nmより
長波長での波長領域に分光増感するときに魅力的である
ことが判明した。430nm未満に吸収ピークを有する
一種以上の分光増感色素を含有する超薄平板状粒子が匹
敵する性能を示すことは理論的に可能である。しかしな
がら、当該技術分野では、カメラスピード乳剤の通常固
有青色感度に依存して感度を増加しており、このため青
色露光記録を行うのに超薄平板状粒子乳剤へ移行するの
が遅くなった。平板状粒子の厚さを減少することにより
生じる粒子体積の減少は、青色吸収分光増感色素を用い
ることにより実現されるよりも著しく大きな青色スピー
ドの増加を得る固有青色感度の使用に悪くはたらく。従
って、より厚い平板状粒子若しくは非平板状粒子を選択
するのが、カメラ感度フィルムの青色記録乳剤層につい
ては一般的である。最近、米国特許第5,250,40
3号(Antoniades等)には、本発明の前に、
多くの点で、カラー写真要素、特にスペクトルのマイナ
スブルー(赤色及び/若しくは緑色)部における、光を
記録するための入手可能な最良の乳剤の代表である平板
状粒子乳剤が開示されている。Antoniades等
は、(111)主面を有する平板状粒子が総粒子投影面
積の97%を超える割合を占める平板状粒子乳剤を開示
した。これらの平板状粒子は、平均円相当径(平均EC
D)が少なくとも0.7μmであり、平均厚さが0.0
7μm未満である(平均厚さが0.07μm未満である
平板状粒子乳剤を、以下「超薄」平板状粒子乳剤と称す
る)。超薄平板状粒子乳剤は、乳剤層と下層乳剤層の両
方において、銀が効率的に利用されること、スピード−
粒状度関係が魅力的であること、及び像の鮮鋭度が高レ
ベルであることから、カラー写真要素、特にマイナスブ
ルー記録乳剤層に使用するのに適している。Buhr等
によって、ResearchDisclosure(以
下、RDとする)、第253巻、アイテム25330、
1985年5月に開示されているように、0.18〜
0.08μmの範囲の厚さを有する平板状粒子の特徴で
あると認識されているように、超薄平板状粒子乳剤と他
の平板状粒子乳剤とを区別する特徴は、可視スペクトル
内で最大反射を示さないことである。RDは、英国ハン
プシヤー州PO10 7DQ エムスワース 12ノー
スストリートダッドレーアネックスにあるKennet
h Mason Publications社により発
行されている。多層写真要素では、平均平板状粒子厚さ
が0.18〜0.08μmの範囲である上層乳剤層は、
反射特性が可視スペクトル内で大きく異なるので選択に
注意を要する。多層写真要素の構成に超薄平板状粒子乳
剤を選択すると、他の乳剤層の上に位置する上記種々の
乳剤層において異なる平均粒子厚さを分光反射率に応じ
て選択する必要がなくなる。従って、超薄平板状粒子乳
剤は、単に写真性能を向上できるだけでなく、多層写真
要素の構成を簡素化する利点もある。別法の一つとし
て、RD(第308巻、1989年12月、アイテム3
08119、セクションI、パラグラフD)に開示され
ているように、Antoniades等は超薄平板粒子
にイオン性ドーパントを内蔵させることを考えた。還元
増感の試みは古くから検討されており、Carroll
は米国特許第2,487,850号において錫化合物
が、Loweらは同第2,512,925号においてポ
リアミン化合物が、Fallensらは英国特許第78
9,823号において二酸化チオ尿素系の化合物が、夫
々還元増感剤として有用であることが開示されている。In 1982, first indirect radiographic and color photographic films incorporating the disclosure of Kofron et al. Were introduced commercially. Fifteen years later, it is clearly understood that different tabular grain emulsions are preferred depending on the type of product contemplated. Indirect radiography has been found to be unattractive since ultrathin tabular grain emulsions produce silver with an unfavorable temperature (ie, brownish black) image tone. In camera speed color photographic films, ultrathin tabular grain emulsions are usually attractive, especially when spectrally sensitized to wavelength regions where intrinsic grain sensitivity is low, for example, wavelengths longer than about 430 nm. Turned out to be. It is theoretically possible for ultrathin tabular grains containing one or more spectral sensitizing dyes having an absorption peak below 430 nm to exhibit comparable performance. However, the art has increased sensitivity depending on the usually intrinsic blue sensitivity of camera speed emulsions, which has slowed the transition to ultrathin tabular grain emulsions for performing blue exposure recording. The reduction in grain volume caused by reducing the thickness of the tabular grains adversely affects the use of intrinsic blue sensitivity which results in a significantly greater increase in blue speed than is realized by using blue absorbing spectral sensitizing dyes. Therefore, it is common to select thicker tabular or non-tabular grains for the blue recording emulsion layer of a camera speed film. Recently, US Patent No. 5,250,40
No. 3 (Antoniades et al.), Prior to the present invention,
In many respects, tabular grain emulsions are disclosed which are representative of the best emulsions available for recording light in color photographic elements, especially in the minus blue (red and / or green) portion of the spectrum. Antoniades et al. Disclosed tabular grain emulsions in which tabular grains having (111) major faces accounted for more than 97% of total grain projected area. These tabular grains have an average equivalent circle diameter (average EC
D) is at least 0.7 μm and the average thickness is 0.0
Less than 7 μm (tabular grain emulsions having an average thickness of less than 0.07 μm are hereinafter referred to as “ultra-thin” tabular grain emulsions). Ultrathin tabular grain emulsions provide efficient silver utilization in both the emulsion and lower emulsion layers, speed-
The attractiveness of the granularity relationship and the high level of image sharpness make it suitable for use in color photographic elements, especially minus blue recording emulsion layers. Research Disclosure (hereinafter referred to as RD), Volume 253, Item 25330, by Buhr et al.
As disclosed in May 1985, 0.18 to
As is recognized as a feature of tabular grains having a thickness in the range of 0.08 μm, the feature that distinguishes ultrathin tabular grain emulsions from other tabular grain emulsions is the largest in the visible spectrum. It does not show reflection. RD is located at Kennet at PO10 7DQ Emsworth 12 North Street Dudley Annex, Hampshire, UK
h Published by Mason Publications. In a multilayer photographic element, the upper emulsion layer having an average tabular grain thickness in the range of 0.18 to 0.08 µm comprises:
Care must be taken in the selection as the reflection properties vary greatly within the visible spectrum. The choice of ultrathin tabular grain emulsions in the construction of the multilayer photographic element obviates the need to select different average grain thicknesses for the various emulsion layers above other emulsion layers depending on spectral reflectance. Thus, ultrathin tabular grain emulsions not only can improve photographic performance, but also have the advantage of simplifying the construction of multilayer photographic elements. As an alternative, RD (Vol. 308, December 1989, Item 3
As disclosed in US Pat. No. 08119, Section I, paragraph D), Antoniades et al. Considered incorporating ionic dopants into ultrathin tabular grains. Attempts to reduce sensitization have been considered for a long time, and Carroll
U.S. Pat. No. 2,487,850 discloses a tin compound, Lowe et al. Discloses a polyamine compound in U.S. Pat. No. 2,512,925, and Fallens et al.
No. 9,823 discloses that thiourea dioxide compounds are each useful as a reduction sensitizer.
【0004】更に、CollierはPhotogra
phic Science andEngineeri
ng 23巻113頁(1979)において、種々の還
元増感法によって作られた銀核の性質を比較している。
彼女は、例えば、ジメチルアミノボラン、塩化第一錫、
ヒドラジン、高pH熟成、低pAg熟成を用いた方法を
採用した。還元増感の方法は更に米国特許第2,51
8,698号、同第3,201,254号、同第3,4
11,917号、同第3,779,777号、同第3,
930,867号にも開示されている。還元増感剤の選
択だけでなく還元剤の使用方法に関しては特公昭57−
33572号、同58−1410号、特開昭57−17
9835号に開示されている。更に還元増感した乳剤の
保存性を改良する技術に関しても特開昭57−8283
1号、同60−178445号に開示されている。又、
還元増感は、ジェームス(T.H.James)著、ザ
・フォトグラフィック・プロセス、第4版、マクミラン
社刊、1977年、(T.H.Jaimes、The
Theory of the Photographi
c Process,4thed,Macmilla
n,1977)152頁に記載されているように、還元
増感により生成した2原子による銀核が正孔を捕獲する
ことにより、銀イオンと不安定な銀原子に分解し、更に
熱的に不安定な銀原子が銀イオンと伝導体電子に分解
し、その電子が潜像形成に寄与する、という機構も考え
られている。この機構によると感度を最大2倍に増大さ
せることが可能である。又、特開平8−211525号
に超薄平板状粒子乳剤と表面に還元増感を併用した特許
が開示されているが、この場合の還元増感の行われる箇
所は表面であり、表面に還元増感した場合、チオスルホ
ン酸等の酸化剤を併用してもカブリが高すぎて効果とし
て十分ではなかった。又、特開平2−191938号、
特開平8−29911号に還元増感とチオスルホン酸の
組み合わせの特許が開示されているが、この技術だけで
は感度−カブリは改善されても、鮮鋭度の改良に関して
は不十分であった。[0004] Furthermore, Collier is a Photograph.
phic Science and Engineeri
ng 23: 113 (1979) compares the properties of silver nuclei made by various reduction sensitization methods.
She has, for example, dimethylaminoborane, stannous chloride,
A method using hydrazine, high pH aging, and low pAg aging was employed. The method of reduction sensitization is further described in U.S. Pat.
No. 8,698, No. 3,201,254, No. 3,4
No. 11,917, No. 3,779,777, No. 3,
No. 930,867. Regarding the method of using the reducing agent as well as the selection of the reduction sensitizer,
No. 33572, No. 58-1410, JP-A-57-17
No. 9835. Further, a technique for improving the storage stability of the reduction-sensitized emulsion is disclosed in JP-A-57-8283.
Nos. 1 and 60-178445. or,
Reduction sensitization is described in TH James, The Photographic Process, 4th Edition, published by Macmillan, 1977, (TH James, The.
Theory of the Photographi
c Process, 4thed, Macmilla
n, 1977), p. 152, the silver nucleus formed by the two atoms generated by reduction sensitization captures holes, thereby decomposing into silver ions and unstable silver atoms, and further thermally. A mechanism has been considered in which unstable silver atoms are decomposed into silver ions and conductor electrons, and the electrons contribute to latent image formation. According to this mechanism, it is possible to increase sensitivity up to twice. Japanese Patent Application Laid-Open No. 8-21525 discloses a patent in which an ultra-thin tabular grain emulsion is used in combination with reduction sensitization on the surface. In this case, the reduction sensitization is performed on the surface, and the surface is reduced. In the case of sensitization, fogging was too high even when an oxidizing agent such as thiosulfonic acid was used in combination, and was not sufficient as an effect. Also, JP-A-2-191938,
Japanese Patent Application Laid-Open No. 8-29911 discloses a patent for a combination of reduction sensitization and thiosulfonic acid, but this technique alone does not sufficiently improve the sharpness, although the sensitivity-fog is improved.
【0005】[0005]
【発明が解決しようとする課題】一般の平板状粒子乳剤
の数多くの利点及びAntoniades等により開示
されている改良点を含む超薄平板状粒子乳剤及びカラー
写真要素による特定の改良点にもかかわらず、これらの
乳剤を含有する写真要素のみならず、今まで当該技術分
野において得ることのできなかった超薄平板状粒子乳剤
における性能向上並びにカラー写真について達成できる
最高性能の乳剤及び写真要素を構成するための別の選択
の満たされてない必要性が残っている。更に、超薄平板
状粒子乳剤は、乳剤層と下部乳剤層の両方において、銀
が効率的に利用されること、感度−粒状度関係が魅力的
であること、及び像の鮮鋭度レベルが高いことから、特
にマイナスブルー記録乳剤層に使用するのに適している
が、ブルー記録乳剤に使用するには非常に薄いために感
度の面では不十分であった。Despite the numerous advantages of general tabular grain emulsions and the particular improvements provided by ultrathin tabular grain emulsions and color photographic elements, including the improvements disclosed by Antoniades et al. Constitutes the highest performance emulsions and photographic elements that can be achieved not only in photographic elements containing these emulsions, but also in ultrathin tabular grain emulsions previously unattainable in the art and in color photography. There remains an unmet need for another option. In addition, ultrathin tabular grain emulsions have efficient silver utilization, attractive speed-granularity relationships, and high levels of image sharpness, in both the emulsion and lower emulsion layers. For this reason, it is particularly suitable for use in a minus blue recording emulsion layer, but is insufficient in sensitivity because it is very thin for use in a blue recording emulsion.
【0006】本発明は上記事情に鑑みてなされたもので
あり、その目的は、ブルー記録乳剤に使用するのに十分
な感度を有し、低カブリで鮮鋭度の良い超薄平板状粒子
を用いたハロゲン化銀乳剤及びマイナスブルー記録の更
なる性能向上を達成する超薄平板状粒子乳剤を用いた写
真感光材料を提供することである。The present invention has been made in view of the above circumstances, and an object of the present invention is to use ultra-thin tabular grains having sufficient sensitivity for use in a blue recording emulsion, low fog and good sharpness. It is another object of the present invention to provide a photographic material using a silver halide emulsion and an ultra-thin tabular grain emulsion which achieves further improvement in the performance of minus blue recording.
【0007】[0007]
【課題を解決するための手段】本発明の上記目的は、以
下の構成により達成された。The above object of the present invention has been attained by the following constitutions.
【0008】〈1〉 (111)主面を有し、平均臭化
銀含有率が70mol%以上、平均円相当径が0.7μ
m以上であり、かつ平均粒子厚さが0.07μm未満の
平板状ハロゲン化銀粒子が全投影面積の90%以上を占
めるハロゲン化銀乳剤であって、その製造工程中に、前
記平板状ハロゲン化銀粒子内部に還元増感を施こし、か
つ下記一般式(1)乃至(3)で表される化合物から選
ばれる少なくとも1種を添加された乳剤であることを特
徴とするハロゲン化銀乳剤。<1> It has a (111) main surface, an average silver bromide content of 70 mol% or more, and an average equivalent circle diameter of 0.7 μm.
m or more, and wherein the tabular silver halide grains having an average grain thickness of less than 0.07 μm occupy 90% or more of the total projected area. A silver halide emulsion characterized by being subjected to reduction sensitization inside silver halide grains and containing at least one compound selected from the compounds represented by the following formulas (1) to (3): .
【0009】一般式 (1) R−SO2S−M (2) R−SO2S−R1 (3) R−SO2S−Lm−SSO2−R2 式中、R、R1、R2は脂肪族基、脂環式(化合物残)
基、芳香族基或いはヘテロ環基を表し、各々同一でも異
なってもよく、又Mは陽イオンを表す。Lは二価の連結
基を表し、mは0又は1である。上記一般式(1)乃至
(3)の化合物は、該(1)乃至(3)で示す構造から
誘導される2価の基を繰り返し単位として含有するポリ
マーであっても良い。又可能なときはR、R1、R2、L
が互いに結合して環を形成しても良い。The general formula (1) R-SO 2 SM (2) R-SO 2 SR 1 (3) R-SO 2 SL m -SSO 2 -R 2 In the formula, R and R 1 , R 2 is an aliphatic group, an alicyclic group (remaining compound)
Represents an aromatic group or a heterocyclic group, which may be the same or different, and M represents a cation. L represents a divalent linking group, and m is 0 or 1. The compounds of the above general formulas (1) to (3) may be polymers containing, as a repeating unit, a divalent group derived from the structure shown in the above (1) to (3). When possible, R, R 1 , R 2 , L
May combine with each other to form a ring.
【0010】好ましい態様として、前記平板状ハロゲン
化銀粒子がドーパントを含むこと、又前記ハロゲン化銀
粒子が表面に潜像形成性化学増感部位を有し、該部位が
エピタキシャル配置された少なくとも1種のハロゲン化
銀突起部を含むこと、が挙げられる。In a preferred embodiment, the tabular silver halide grains contain a dopant, and the silver halide grains have a latent image forming chemical sensitizing site on the surface thereof, and the site has at least one chemically sensitized site. And silver halide projections.
【0011】〈2〉 上記の何れか1つに記載のハロゲ
ン化銀乳剤を含むことを特徴とする写真感光材料。<2> A photographic light-sensitive material comprising the silver halide emulsion described in any one of the above.
【0012】ハロゲン化銀乳剤の高感度化のために様々
な検討が行なわれており、着実な進歩が得られている。
しかし、撮影感材としての銀の効率的利用、感度、カブ
リ−粒状度関係の同時改良、像の鮮鋭度及び上記特性と
保存安定性の両立の要請は大きく、まだまだ満足できる
レベルではない。Various studies have been made to increase the sensitivity of silver halide emulsions, and steady progress has been made.
However, there are great demands for efficient use of silver as a photographic material, simultaneous improvement of sensitivity, fog-granularity relation, sharpness of an image, and compatibility between the above characteristics and storage stability, which are still not at a satisfactory level.
【0013】従って、本発明者らは鋭意検討した結果、
ハロゲン化銀乳剤の製造工程において、ハロゲン化銀粒
子を超薄にすることによりブルー記録に不利となった感
度に対し、粒子内部に還元増感を施こし、その結果生じ
る高カブリを特定構造を有するチオスルホン酸誘導体を
用いることにより抑制でき、それに伴い感度、カブリ、
鮮鋭度を飛躍的に向上できるとの知見に基づき、本発明
に至ったものである。更にはマイナスブルー記録に関し
ても上記特性の更なる向上を達成したものである。Accordingly, the present inventors have conducted intensive studies and as a result,
In the manufacturing process of silver halide emulsions, reduction sensitivity was applied to the inside of the grains, whereas the sensitivity which was disadvantageous for blue recording by making the silver halide grains ultra-thin, the resulting high fog was reduced to a specific structure. Can be suppressed by using a thiosulfonic acid derivative having the sensitivity, fog,
The present invention has been made based on the finding that sharpness can be dramatically improved. Further, with respect to minus blue recording, the above characteristics are further improved.
【0014】以下、本発明を詳細に説明する。Hereinafter, the present invention will be described in detail.
【0015】本発明はスペクトル増感写真乳剤の向上に
関する。本発明に用いられるハロゲン化銀乳剤(以下、
単に本発明の乳剤ともいう。)は具体的にはカメラ感度
カラー写真フィルムへの組み込みを意図している。本発
明の乳剤は、平板状粒子が、(a)(111)主面を有
し、(b)銀に対して70モル%を超える臭化物を含有
し、(c)総粒子投形面積の90%を超える割合を占
め、(d)少なくとも0.7μmの平均円相当径(平均
ECD)を示し、そして(e)0.07μm未満の平均
厚さを示す、通常の超薄平板状粒子乳剤を化学的及び分
光的に増感することにより実現することができる。基準
(a)〜(e)は厳しすぎて大多数の公知の平板状粒子
乳剤によっては満足されないが、2、3の公開されてい
る沈殿法によりこれらの基準を満足する乳剤を製造する
ことができる。上記したAntoniades等は、こ
れらの基準を満足する好ましいヨウ臭化銀乳剤を示して
いる。欧州特許第362,699A3号(Zola及び
Bryant)も、これらの基準を満足するヨウ臭化銀
乳剤が開示されている。The present invention relates to the enhancement of spectrally sensitized photographic emulsions. The silver halide emulsion used in the present invention (hereinafter, referred to as “silver halide emulsion”)
It is simply called the emulsion of the present invention. ) Is specifically intended for incorporation into camera speed color photographic film. In the emulsion of the present invention, the tabular grains have (a) (111) major faces, (b) more than 70 mol% bromide based on silver, and (c) 90% of the total grain casting area. % Ultra-thin tabular grain emulsions which account for more than 1% of the total (d) exhibit an average equivalent circular diameter (mean ECD) of at least 0.7 μm and (e) exhibit an average thickness of less than 0.07 μm. It can be realized by chemical and spectral sensitization. Criteria (a)-(e) are too stringent to be satisfied by the majority of known tabular grain emulsions, but a few published precipitation methods can produce emulsions that meet these criteria. it can. Antoniades et al., Supra, indicate preferred silver iodobromide emulsions that meet these criteria. EP 362,699 A3 (Zola and Bryant) also discloses silver iodobromide emulsions meeting these criteria.
【0016】複数のハロゲン化物を含有する粒子及び乳
剤について、ハロゲン化物を濃度の上昇順序で記載す
る。本発明において、「超薄」の用語は、0.07μm
未満の平均粒子厚さを有する平板状粒子を示すために用
い、従って、該平板状粒子を超薄平板状粒子ともいう。
カメラ感度フィルムの場合、平板状粒子は、一般的にヨ
ウ化物を銀に対して少なくとも0.25モル%、好まし
くは少なくとも1.0モル%含有することが好ましい。
又これらの低レベルのヨウ化物は、本発明の乳剤に含有
される超薄平板状粒子においても企図される。しかし、
超薄平板状粒子のヨウ化物は、本発明のスピード−粒状
度の利点の実現には必要でない。超薄臭化銀粒子は、乳
剤調製時若しくは調製後の保存時に形態崩壊(例えば、
肥大化)を非常に受けやすいので、超薄平板状粒子を形
態的に安定化する便宜性として、代わりにヨウ化物を組
み入れることが考えられる。本発明の乳剤に含有される
超薄平板状粒子は、全ての場合において、10モル%未
満のヨウ化物、好ましくは6モル%未満のヨウ化物、最
適には4モル%未満のヨウ化物を含有することが好まし
い。超薄平板状粒子に少量の塩化物イオンを含ませるこ
とも可能である。米国特許第5,372,927号(D
elton)に開示されているように、総銀に対して塩
化物0.4〜20モル%及びヨウ化物10モル%以下を
含有し、ハロゲン化物の残部が臭化物である超薄平板状
粒子を含有する乳剤は、米国特許第5,061,609
号及び同第5,061,616号(Piggin等)の
曲線A及びBに相当するDeltonにより示された曲
線AのpAg一温度(℃)境界内(好ましくは曲線Bの
境界内)の総銀の5〜90%を占める粒子成長を行うこ
とにより調製することができる。これらの沈殿条件下で
は、塩化物イオンの存在は、実際に平板状粒子の厚さの
減少に役立つ。For grains and emulsions containing multiple halides, the halides are described in order of increasing concentration. In the present invention, the term “ultra-thin” refers to 0.07 μm
Used to indicate tabular grains having an average grain thickness of less than, and are therefore also referred to as ultrathin tabular grains.
In the case of a camera sensitivity film, the tabular grains generally contain at least 0.25 mol%, preferably at least 1.0 mol%, of iodide with respect to silver.
These low levels of iodide are also contemplated in ultrathin tabular grains contained in the emulsions of the present invention. But,
Ultrathin tabular grain iodide is not required to realize the speed-granularity benefits of the present invention. Ultra-thin silver bromide grains undergo morphological collapse (e.g.,
(I.e., enlargement), it is conceivable to incorporate iodide instead as a convenience for morphologically stabilizing the ultrathin tabular grains. The ultrathin tabular grains contained in the emulsions of the invention will in all cases contain less than 10 mol% iodide, preferably less than 6 mol% iodide and optimally less than 4 mol% iodide. Is preferred. Ultrathin tabular grains can also contain small amounts of chloride ions. U.S. Pat. No. 5,372,927 (D
ultra-thin tabular grains containing from 0.4 to 20 mole percent chloride and up to 10 mole percent iodide, with the balance halide being bromide, as disclosed in US Pat. The emulsion is described in U.S. Pat. No. 5,061,609.
No. 5,061,616 (Piggin et al.) Total silver within the pAg-Temperature (° C.) boundary (preferably within the boundary of Curve B) of Curve A shown by Delton corresponding to Curves A and B Can be prepared by growing particles occupying 5-90% of the total. Under these precipitation conditions, the presence of chloride ions actually helps reduce the thickness of the tabular grains.
【0017】塩化物イオン(存在するとき)に対して
は、平板状粒子の厚さの減少に役立つことができる沈殿
条件を用いることが好ましいが、塩化物イオンは、平板
状粒子の平均厚さ0.07μm未満の保持と適合する程
度まで通常の超薄平板状粒子が沈殿中に添加できること
が認識される。総粒子投影面積(全投影面積)の少なく
とも90%を占める超薄平板状粒子は、銀に対して臭化
物を少なくとも70モル%含有することが必須であり、
そしてヨウ化物を少なくとも0.25モル%含有するの
が好ましい。これらの超薄平板状粒子には、ヨウ臭化銀
及び塩ヨウ臭化銀粒子が含まれることが好ましい。超薄
平板状粒子の組成に言及する場合は全てハロゲン化銀エ
ピタキシーを除く。超薄平板状粒子内のヨウ化物を、都
合の良いように平板状粒子内に均一にも不均一にも分布
させることができる。For chloride ions (when present), it is preferred to use precipitation conditions that can help reduce the thickness of the tabular grains, but chloride ions are used to reduce the average thickness of the tabular grains. It is recognized that ordinary ultrathin tabular grains can be added during precipitation to an extent compatible with retention of less than 0.07 μm. Ultrathin tabular grains occupying at least 90% of the total grain projected area (total projected area) must contain at least 70 mol% bromide relative to silver;
And it is preferable to contain iodide at least 0.25 mol%. These ultrathin tabular grains preferably contain silver iodobromide and silver chloroiodobromide grains. All references to the composition of ultrathin tabular grains exclude silver halide epitaxy. The iodide in the ultrathin tabular grains can be conveniently or uniformly distributed within the tabular grains.
【0018】Antoniades等の乳剤例は、比較
的均一なヨウ化物分布を例示している。米国特許第4,
433,048号(Solberg等)には、スピード
を低下させることなしに粒状度を小さくすることができ
る不均一なヨウ化物プロフィールが開示されている。A
ntoniades等、Zola及びBryant並び
にDeltonの開示によって生成される超薄平板状粒
子は、全て(111)主面を有している。このような平
板状粒子は、典型的には三角若しくは六角主面を有して
いる。粒子の平板状構造は平行双晶面を含むことに起因
している。The emulsion examples of Antoniades et al illustrate a relatively uniform iodide distribution. U.S. Patent No. 4,
No. 433,048 (Solberg et al.) Discloses a non-uniform iodide profile which can reduce granularity without reducing speed. A
Ultrathin tabular grains produced according to the disclosures of Zona and Bryant and Delton, et al., have a (111) major surface. Such tabular grains typically have a triangular or hexagonal major surface. The tabular structure of the grains results from the inclusion of parallel twin planes.
【0019】本発明の乳剤に含有される平板状粒子は、
総粒子投影面積の90%以上の割合を占める。平板状粒
子が総粒子投影面積の97%を超える割合を占める超薄
平板状粒子乳剤は、Antoniades等により開示
される調製法により製造でき且つ好ましい。Anton
iades等は、総粒子投影面積99%越える割合(実
質的に全て)を平板状粒子により占められているハロゲ
ン化銀乳剤を報告している。同様に、Deltonは、
超薄平板状粒子乳剤を形成する際に沈殿する粒子の「実
質的に全て」が平板状であったことを報告している。平
板状粒子が総粒子投影面積の高い割合を占める乳剤を提
供することは、特に多層カラー写真フィルムにおける最
大達成可能像鮮鋭度レベルを達成するために重要であ
る。又、銀を効率的に利用すること及び最も望ましいス
ピード−粒状度関係を達成することも重要である。総粒
子投影面積の90%以上の割合を占める平板状粒子は、
平均ECDが少なくとも0.7μmであることを必須と
する。平均ECDを少なくとも0.7μmに維持するこ
とにより実現される利点は、Antoniades等の
表III及びIVに示されている。極めて大きな平均ECD
を有する乳剤は科学的粒子研究用に調製されることがあ
るが、写真用途の場合、平均ECDは通常10μm未満
であり、ほとんどの場合5μm未満である。中位〜高位
の像構造品質に関する最適な平均ECDの範囲は、1〜
4μmの範囲である。The tabular grains contained in the emulsion of the present invention include:
It accounts for 90% or more of the total grain projected area. Ultrathin tabular grain emulsions in which tabular grains account for greater than 97% of total grain projected area can be prepared and are preferred by the preparation methods disclosed by Antoniades et al. Anton
report silver halide emulsions in which tabular grains account for over 99% (substantially all) of the total grain projected area. Similarly, Delton
It is reported that "substantially all" of the grains that precipitate when forming ultrathin tabular grain emulsions were tabular. Providing emulsions in which tabular grains account for a high percentage of the total grain projected area is important to achieve the highest achievable image sharpness levels, especially in multilayer color photographic films. It is also important to utilize silver efficiently and to achieve the most desirable speed-granularity relationship. Tabular grains accounting for 90% or more of the total grain projected area are:
It is essential that the average ECD is at least 0.7 μm. The benefits realized by keeping the average ECD at least 0.7 μm are shown in Tables III and IV of Antoniades et al. Extremely large average ECD
May be prepared for scientific grain studies, but for photographic applications the average ECD is usually less than 10 μm and most often less than 5 μm. The optimal average ECD range for medium to high image structure quality is 1 to
The range is 4 μm.
【0020】本発明の超薄平板状粒子含有乳剤におい
て、総粒子投影面積の90%以上の割合を占める平板状
粒子は平均粒子厚さ(平均厚さともいう)が0.07μ
m未満である。平均粒子厚さが0.07μmで、スペク
トルの緑色領域及び赤色領域間における反射率の変動が
ほとんどない。更に、平均粒子厚さ0.08〜0.20
μmの範囲を有する平板状粒子を含有する乳剤と比較し
て、マイナスブルー反射率と青色反射率との間の差は大
きくない。可視領域における露光波長からの反射率の大
きさのデカップリングにより、緑色及び赤色記録乳剤
(及びより低程度青色記録乳剤)が同一若しくは類似の
平板状粒子を含有する乳剤を用いて構成できる点でフィ
ルム構成が簡略化される。もし平板状粒子の平均粒子厚
さを更に0.05μm未満に薄くするならば、可視スペ
クトル内で観察される平均反射率も減少する。従って、
平均粒子厚さを0.05μm未満に維持することが好ま
しい。一般的に、沈殿法によって都合よく実現される最
小の平均粒子厚さが好ましい。In the emulsion containing ultrathin tabular grains of the present invention, tabular grains occupying 90% or more of the total grain projected area have an average grain thickness of 0.07 μm.
m. With an average grain thickness of 0.07 μm, there is little variation in reflectance between the green and red regions of the spectrum. Further, the average particle thickness is 0.08 to 0.20.
Compared to emulsions containing tabular grains having a range of μm, the difference between minus blue reflectance and blue reflectance is not great. By decoupling the magnitude of the reflectance from the exposure wavelength in the visible region, green and red recording emulsions (and to a lesser extent blue recording emulsions) can be constructed using emulsions containing the same or similar tabular grains. The film configuration is simplified. If the average grain thickness of the tabular grains is further reduced to less than 0.05 μm, the average reflectance observed in the visible spectrum will also decrease. Therefore,
Preferably, the average grain thickness is kept below 0.05 μm. Generally, the smallest average grain thickness conveniently achieved by the precipitation method is preferred.
【0021】このようにして、平均粒子厚さが約0.0
3〜0.05μmの範囲である超薄平板状粒子含有乳剤
が容易に実現される。米国特許第4,672,027号
(Daubendiek等)は、平均粒子厚さ0.01
7μmを報告している。Antoniades等により
開示されている粒子成長法を利用して、これらの乳剤
を、認められるほどの厚さの増加がなく、例えば、平均
粒子厚さ0.02μm未満を維持しながら平均ECDを
少なくとも0.7μmまで成長できる。平板状粒子の最
小の平均粒子厚さは、沈殿中粒子に形成される最初の2
つの平行双晶面の間隔により限定される。0.002μ
m(即ち、2nm若しくは20オングストローム)の小
さな最小双晶面間隔がAntoniades等の乳剤に
おいて観察されたが、Kofron等は、実用最小平均
粒子厚さ約0.01μmを示唆している。本発明におい
て、好ましい超薄平板状粒子を含有する乳剤は、粒子間
の変動が低レベルに保持されるものである。Anton
iades等は、平板状粒子の90%を超える部分が六
角主面を有する超薄平板状粒子含有の乳剤を報告してい
る。又、Antoniadesは、平均ECDに対する
変動係数(COV)が25%未満及び20%未満の場合
もある超薄平板状粒子を含有する乳剤も報告している。
写真感度及び粒状度が平均ECDの増加とともに増加す
ることが認められる。異なる平均ECDを有する最適増
感乳剤の感度と粒状度の比較から、当該技術分野では、
スピードが2倍(即ち、スピードで0.3logE増加
する、ここでEは露光量(ルックス−秒)である)増加
するごとに、同じスピード−粒状度関係を示す乳剤の粒
状度が7粒状度単位増加することが立証されている。本
発明の乳剤では、より大きな平均ECDを有する粒子が
小さな割合でも存在すると、乳剤の粒状度が顕著に増加
することが観察された。Antoniades等は、C
OVを制限すると存在する平板状粒子の平均ECDが必
ず平均値に近くなるので、低COV乳剤を好ましいもの
とした。本発明によれば、COVは乳剤の粒状度を判断
する上での最良の手法ではない。低乳剤COV値を必要
とすると、平均ECDよりも大きい粒子集団と小さい粒
子集団の両方が制限されるのに対して、粒状度を高レベ
ルにするのは前者の粒子集団のみである。当該技術での
全体COV測定値の信憑性は、粒度一頻度分布(分散が
広いか狭いかどうか)が、沈殿法に固有の且つ容易に制
御できない正規誤差関数分布であるとの仮定に基づいて
いる。Antoniades等により開示される超薄平
板状粒子沈殿法を変更して、乳剤の平均ECDよりも大
きなECDを示す超薄平板状粒子の粒度−頻度分布を選
択的に小さくすることが具体的に意図される。平均値よ
りも小さいECDを有する粒子の粒度−頻度分布は対応
して小さくならないので、全体COV値は認知できるほ
どには減少しない。しかしながら、乳剤粒状度を小さく
する利点は明確に立証されている。平均ECDよりも大
きい超薄平板状粒子の粒度−頻度分布における不均化サ
イズ範囲の減少は、以下の方法で超薄平板状粒子を含有
する乳剤の沈殿法を変更することにより実現できること
が判明した。即ち、超薄平板状粒子の核形成を天然メチ
オニン含量を減少させる処理をしていないゼラチン状解
こう剤を用いて行う一方、存在するゼラチン状解こう剤
及び後で導入したゼラチン状解こう剤のメチオニン分を
実質的に除去した後に粒子成長を行う。これを達成する
のに都合のよい手法は、核形成後でメチオニン酸化剤を
導入するに十分な程度に成長が進行す前に沈殿を中断す
ることである。ゼラチン状解こう剤のメチオニンを酸化
するための従来の手法のいずれをも用いることができ
る。米国特許第4,713,320号(Maskask
y 以下、「Maskasky II」という)には、酸
化によりメチオニンレベルを、ゼラチン1グラム当たり
30μモル未満、好ましくは強力な酸化剤を用いること
により12μモル未満に減少させることが開示されてい
る。Thus, the average grain thickness is about 0.0
Ultrathin tabular grain-containing emulsions in the range of 3 to 0.05 µm are easily realized. U.S. Patent No. 4,672,027 (Daubendiek et al.) Discloses an average grain thickness of 0.01.
7 μm is reported. Utilizing the grain growth method disclosed by Antoniades et al., These emulsions can be prepared without any appreciable thickness increase, e.g., with an average ECD of at least 0, while maintaining an average grain thickness of less than 0.02 .mu.m. It can grow to 0.7 μm. The minimum average grain thickness of the tabular grains is the first two grains formed in the grains during precipitation.
It is limited by the distance between two parallel twin planes. 0.002μ
Small minimum twin plane spacings of m (ie, 2 nm or 20 angstroms) have been observed in emulsions such as Antoniades, but Kofron et al. suggest a practical minimum average grain thickness of about 0.01 μm. In the present invention, emulsions containing preferred ultrathin tabular grains are those in which the variation between grains is kept at a low level. Anton
Iades et al. report emulsions containing ultrathin tabular grains in which more than 90% of the tabular grains have a hexagonal major surface. Antoniades also reports emulsions containing ultrathin tabular grains that have a coefficient of variation (COV) to average ECD of less than 25% and sometimes less than 20%.
It can be seen that photographic speed and granularity increase with increasing average ECD. From a comparison of the sensitivity and granularity of optimally sensitized emulsions with different average ECDs,
For each doubling of speed (ie, 0.3 log E increase in speed, where E is the exposure (lux-seconds)), the granularity of the emulsion exhibiting the same speed-granularity relationship is 7 granularities. Units have been proven to increase. In the emulsions of the present invention, it was observed that the graininess of the emulsion was significantly increased when a small percentage of grains having a higher average ECD were present. Antoniades et al., C
If the OV is restricted, the average ECD of the tabular grains present always approaches the average value, so that a low COV emulsion was preferred. According to the present invention, COV is not the best way to determine the granularity of an emulsion. The need for low emulsion COV values limits both the population of grains larger and smaller than the average ECD, while only the former population provides a higher level of granularity. The authenticity of the overall COV measurement in the art is based on the assumption that the particle size-frequency distribution (whether the variance is wide or narrow) is a normal error function distribution that is inherent in sedimentation methods and cannot be easily controlled. I have. It is specifically intended to modify the ultrathin tabular grain precipitation method disclosed by Antoniades et al. To selectively reduce the particle size-frequency distribution of ultrathin tabular grains exhibiting an ECD greater than the average ECD of the emulsion. Is done. The overall COV value does not decrease appreciably since the particle size-frequency distribution of particles having an ECD below the average is not correspondingly reduced. However, the benefits of reducing emulsion granularity have been clearly demonstrated. It has been found that a reduction in the disproportionate size range in the particle size-frequency distribution of ultrathin tabular grains greater than the average ECD can be achieved by modifying the precipitation method for emulsions containing ultrathin tabular grains in the following manner. did. That is, the nucleation of ultrathin tabular grains is performed using a gelatinous peptizer that has not been treated to reduce the natural methionine content, while the existing gelatinous peptizer and the later introduced gelatinous peptizer After substantially removing the methionine content from the above, the particles are grown. A convenient approach to accomplish this is to interrupt precipitation after nucleation and before growth has progressed to a sufficient degree to introduce a methionine oxidizing agent. Any of the conventional techniques for oxidizing the gelatinous peptizer methionine can be used. U.S. Pat. No. 4,713,320 (Masksk)
y, hereinafter referred to as “Maskasky II”), discloses that oxidation reduces methionine levels to less than 30 μmol per gram of gelatin, preferably to less than 12 μmol by using a strong oxidizing agent.
【0022】事実、Maskasky IIが用いる酸化
剤処理により、メチオニンが検出限界未満に減少する。
ゼラチン状解こう剤中のメチオニンを酸化するために用
いられる薬剤としては、例えば、NaOCl、クロラミ
ン、一過硫酸カリウム、過酸化水素及び過酸化物放出化
合物並びにオゾンが挙げられる。米国特許第4,94
2,120号(King等)は、ゼラチン状解こう剤の
メチオニン成分をアルキル化剤で酸化することを開示し
ている。欧州特許第434,012号(Takada
等)には、上記一般式(1)乃至(3)で表される化合
物のうちの1つである、チオスルホネートの存在下での
沈殿を開示している。In fact, the oxidizing agent treatment used by Maskasky II reduces methionine below the detection limit.
Agents used to oxidize methionine in gelatinous peptizers include, for example, NaOCl, chloramine, potassium monopersulfate, hydrogen peroxide and peroxide releasing compounds, and ozone. US Patent No. 4,94
No. 2,120 (King et al.) Discloses oxidizing the methionine component of a gelatinous peptizer with an alkylating agent. European Patent No. 434,012 (Takada)
And the like) disclose precipitation in the presence of thiosulfonate, which is one of the compounds represented by the general formulas (1) to (3).
【0023】ゼラチン状解こう剤には、ゼラチン、例え
ば、アルカリ処理ゼラチン(家畜、骨若しくは皮ゼラチ
ン)若しくは酸処理ゼラチン(豚の皮ゼラチン)及びゼ
ラチン誘導体、例えば、アセチル化若しくはフタル化ゼ
ラチンが含まれる。Gelatin peptizers include gelatin, for example, alkali-treated gelatin (livestock, bone or hide gelatin) or acid-treated gelatin (pig skin gelatin) and gelatin derivatives, for example, acetylated or phthalated gelatin. It is.
【0024】尚、本発明における平均粒子厚さ、平均円
相当径(平均ECD)、平均ECDに対する変動計数、
平均臭化銀含有率は以下の方法で求められる。In the present invention, the average particle thickness, the average equivalent circle diameter (average ECD), the variation count with respect to the average ECD,
The average silver bromide content is determined by the following method.
【0025】平均粒子厚さは飽和被覆量に必要とされる
1,1′−ジエチル−2,2′−シアニン色素のレベル
を測定し、この色素の溶液吸収計数が77,300リッ
トル/モル-cmであり、1モル当たりの部位面積が0.
566nm2であることを用いて、表面積についての式
を解いて求める。The average grain thickness is measuring the level of 1,1'-diethyl-2,2'-cyanine dye required for saturation coverage, the solution absorption coefficient of the dye is 77,300 liters / mole - cm , and the site area per mole is 0.
Using 566 nm 2 , the equation for the surface area is solved.
【0026】平均円相当径(平均ECD)は以下の方法
で求められる。支持体上に内部標準となる粒径既知のラ
テックスボールと、主平面が基板に平行に配向するよう
にハロゲン化銀粒子とを塗布した試料を作製し、ある角
度からカーボン蒸着によりシャドーを施した後、通常の
レプリカ法によってレプリカ試料を作製する。同試料の
電子顕微鏡写真を撮影し、画像処理装置等を用いて個々
の粒子の投影面積を求める。この場合、粒子の投影面積
は内部標準の投影面積から算出することができる。本発
明において、平均円相当径(平均ECD)は、上記レプ
リカ法を用いてハロゲン化銀乳剤に含まれるハロゲン化
銀粒子を任意に500個以上測定し、それらの算術平均
として求められる値をいう。The average equivalent circle diameter (average ECD) is determined by the following method. A sample was prepared by coating a latex ball having a known particle size as an internal standard on a support and silver halide particles such that the main plane was oriented parallel to the substrate, and shadowing was performed by carbon deposition from a certain angle. Thereafter, a replica sample is prepared by a normal replica method. An electron micrograph of the sample is taken, and the projected area of each particle is determined using an image processing device or the like. In this case, the projected area of the particle can be calculated from the projected area of the internal standard. In the present invention, the average equivalent circle diameter (average ECD) refers to a value obtained by arbitrarily measuring 500 or more silver halide grains contained in a silver halide emulsion using the above-mentioned replica method and calculating the arithmetic average thereof. .
【0027】又、ハロゲン化銀粒子の平均ECDに対す
る変動計数とは、上記測定から得られる値を用いて下記
式によって定義される値である。The variation coefficient with respect to the average ECD of silver halide grains is a value defined by the following equation using the value obtained from the above measurement.
【0028】平均ECDに対する変動計数(%)=(粒
径の標準偏差/粒径の平均)×100 本発明における平均臭化銀含有率は以下の方法で求めら
れる。ハロゲン化銀乳剤にゼラチン分解酵素であるアク
チナーゼ水溶液を添加し、ゼラチン分解を行った後、遠
心分離にてハロゲン化銀粒子のみを取り出し、ハロゲン
化銀溶剤(チオ硫酸アンモニウム)等で溶解し、定量用
ろ紙に滴下後、蛍光X線分析による検量線法により臭素
含有率を求め、その値を平均臭化銀含有率とする。Variation coefficient (%) with respect to average ECD = (standard deviation of particle size / average of particle size) × 100 The average silver bromide content in the present invention is determined by the following method. An aqueous solution of actinase, which is a gelatin-decomposing enzyme, is added to the silver halide emulsion, gelatin is decomposed, and only the silver halide grains are taken out by centrifugation and dissolved with a silver halide solvent (ammonium thiosulfate) or the like, and the quantified After dropping the filter paper, the bromine content is determined by a calibration curve method based on X-ray fluorescence analysis, and the value is defined as the average silver bromide content.
【0029】又、本発明の乳剤に含有される上述した超
薄平板状粒子は、内部に還元増感が施されていることを
特徴としている。本発明の乳剤は粒子の内部に還元増感
が施されている場合に最も増感効果が大きく、又保存か
ぶりも良い。粒子内還元増感を行うには、ハロゲン化銀
粒子の成長中に還元増感を行うことにより達成すること
ができる。ここで言う「成長中に還元増感を行う」と
は、ハロゲン化銀粒子の物理熟成中に還元増感を行って
もよいし、水溶性銀塩及び水溶性ハロゲン化アルカリの
添加中に還元増感を行ってもよいし、又これらの添加を
一時止めた状想で還元増感を施しその後更なる沈殿工程
を行うという方法でもよいことを意味する。The ultrathin tabular grains contained in the emulsion of the present invention are characterized in that reduction sensitization has been performed inside. The emulsion of the present invention has the largest sensitizing effect when the grains are subjected to reduction sensitization, and has good storage fog. Intra-grain reduction sensitization can be achieved by performing reduction sensitization during the growth of silver halide grains. The phrase "perform reduction sensitization during growth" as used herein means that reduction sensitization may be performed during physical ripening of silver halide grains, or reduction during addition of a water-soluble silver salt and a water-soluble alkali halide. It means that sensitization may be carried out, or that a method in which reduction sensitization is carried out in a state in which these additions are temporarily stopped, and then a further precipitation step may be carried out.
【0030】本発明で行われる還元増感とは、ハロゲン
化銀に対して還元増感剤を添加する方法、銀熟成と呼ば
れるpAg1〜7の低pAg雰囲気下でハロゲン化銀粒
子を成長或いは熟成させる方法、高pH熟成と呼ばれる
pH8〜11の高pHの雰囲気で成長させる或いは熟成
させる方法のいずれかを選ぶこともできる。又、これら
のうち2つ以上の方法を併用することもできる。特に、
還元増感剤を添加する方法は還元増感のレベルを微妙に
調節できる点で好ましい方法である。ここで用いられる
還元増感剤としては、例えば、第一錫塩、アミン及びポ
リアミン類、ヒドラジン誘導体、ホルムアミジンスルフ
ィン酸、シラン化合物、ボラン化合物が知られている。
本発明で行われる還元増感にはこれら公知の還元増感剤
を選択して用いることができ、又2種以上の化合物を併
用することもできる。還元増感剤の添加量は乳剤製造条
件に依存するので適宜選ぶ必要があるが、ハロゲン化銀
1モル当たり10-7〜10-2モルの範囲が適当である。
これらの還元増感剤は、例えば、水或いはアルコール
類、グリコール類、ケトン類、エステル類、アミド類の
ような溶媒に溶解され、粒子成長中に添加される。あら
かじめ反応容器に添加するのもよいが、粒子成長の適当
な時期に添加する方が望ましい。又、水溶性銀塩或いは
水溶性アルカリハライドの水溶液にあらかじめ還元増感
剤を添加しておき、これらの水溶液を用いてハロゲン化
銀粒子を沈殿せしめてもよい。この他、粒子成長にとも
なって還元増感剤の溶液を何回かに分けて添加する方
法、連続して長時間添加する方法も好ましい方法であ
る。このようにして粒子内還元を行ったハロゲン化銀粒
子の表面には、還元銀核が存在しないことが好ましい。The reduction sensitization performed in the present invention refers to a method in which a reduction sensitizer is added to silver halide, or growth or ripening of silver halide grains in a low pAg atmosphere of pAg 1 to 7, which is called silver ripening. It is also possible to select any one of a method of growing, and a method of growing or ripening in a high pH atmosphere of pH 8 to 11, which is called high pH ripening. Also, two or more of these methods can be used in combination. Especially,
The method of adding a reduction sensitizer is a preferable method because the level of reduction sensitization can be finely adjusted. As the reduction sensitizer used here, for example, stannous salts, amines and polyamines, hydrazine derivatives, formamidinesulfinic acid, silane compounds and borane compounds are known.
For the reduction sensitization performed in the present invention, these known reduction sensitizers can be selected and used, or two or more compounds can be used in combination. The addition amount of the reduction sensitizer depends on the emulsion production conditions and must be appropriately selected, but is suitably in the range of 10 -7 to 10 -2 mol per mol of silver halide.
These reduction sensitizers are dissolved in, for example, water or a solvent such as alcohols, glycols, ketones, esters, and amides, and added during grain growth. Although it may be added to the reaction vessel in advance, it is preferable to add it at an appropriate time during grain growth. Alternatively, a reduction sensitizer may be added in advance to an aqueous solution of a water-soluble silver salt or a water-soluble alkali halide, and silver halide grains may be precipitated using these aqueous solutions. In addition, a method in which the solution of the reduction sensitizer is added in several portions as the grains grow, and a method in which the solution is continuously added for a long time are also preferable methods. It is preferable that no reduced silver nuclei be present on the surface of the silver halide grains subjected to intragranular reduction in this way.
【0031】表面に還元銀核を存在させずに粒子内還元
増感を行う方法として以下のような方法が挙げられる。
即ち、粒子内部の還元増感を上述したような低pAg熟
成、及び/又は高pH熟成で行った場合には、pAgを
7を超える還元を行えないpAgに戻し、及び/又はp
Hを8未満の還元を行えないpHに戻し、その後最外層
の被覆を行う。又、還元増感剤を用いて粒子内部の還元
増感を行った場合には、特公昭58−1410号に開示
されているように、例えば、ヨードのような酸化剤を添
加する方法もあるが、酸化剤を添加すると化学増感の工
程に至るまでに微量ながら残存し感光核の形成を阻害す
るため写真的に好ましくない。The following method can be used as a method for performing intra-grain reduction sensitization without the presence of reduced silver nuclei on the surface.
That is, when the reduction sensitization inside the grains is performed by the low pAg ripening and / or the high pH ripening as described above, the pAg is returned to a pAg in which the reduction exceeding 7 cannot be performed, and / or pAg cannot be reduced.
The H is returned to a pH below 8 that does not allow reduction, and then the outermost layer is coated. When reduction sensitization inside the grains is performed using a reduction sensitizer, for example, as disclosed in JP-B-58-1410, there is a method of adding an oxidizing agent such as iodine. However, when an oxidizing agent is added, it remains in a very small amount before the chemical sensitization step and inhibits the formation of a photosensitive nucleus, which is not photographically preferable.
【0032】本発明におけるハロゲン化銀粒子において
好ましい方法は、pHを5以下に下げて還元増感剤の反
応を妨げて最外核の被覆を行う方法、還元増感後水洗工
程を経て還元増感剤の除去を行った後最外核の被覆を行
う方法、及び下記一般式(1)乃至(3)で表される化
合物を少なくとも一種存在させた状態で最外核の被覆を
行う方法、から選択される少なくとも一つが挙げられ
る。A preferred method for the silver halide grains in the present invention is a method of coating the outermost nucleus by lowering the pH to 5 or less to hinder the reaction of the reduction sensitizer, or a method of reducing sensitization through a water washing step after reduction sensitization. A method of coating the outermost nucleus after removing the sensitizer, and a method of coating the outermost nucleus in a state where at least one compound represented by the following general formulas (1) to (3) is present: At least one selected from the group consisting of:
【0033】一般式 (1) R−SO2S−M (2) R−SO2S−R1 (3) R−SO2S−Lm−SSO2−R2 一般式(1)乃至(3)のチオスルフォン酸系化合物を
更に詳しく説明すると、R、R1、R2が脂肪族基又は脂
環式(化合物残)基の場合、飽和又は不飽和の、直鎖、
分岐状又は環状の、脂肪族炭化水素基であり、好ましく
は炭素数が1〜22のアルキル基、炭素数が2〜22の
アルケニル基、アルキニル基であり、これらは、置換基
を有していてもよい。アルキル基としては、例えばメチ
ル、エチル、プロピル、ブチル、ペンチル、へキシル、
オクチル、2−エチルヘキシル、デシル、ドデシル、ヘ
キサデシル、オクタデシル、シクロヘキシル、イソプロ
ピル及びt−ブチルが挙げられる。Formula (1) R-SO 2 S-M (2) R-SO 2 S-R 1 (3) R-SO 2 S-L m -SSO 2 -R 2 Formulas (1) through ( 2 ) The thiosulfonic acid-based compound 3) will be described in more detail. When R, R 1 and R 2 are an aliphatic group or an alicyclic (residual compound) group, a saturated or unsaturated, linear,
It is a branched or cyclic aliphatic hydrocarbon group, preferably an alkyl group having 1 to 22 carbon atoms, an alkenyl group having 2 to 22 carbon atoms, or an alkynyl group, which has a substituent. You may. Examples of the alkyl group include methyl, ethyl, propyl, butyl, pentyl, hexyl,
Octyl, 2-ethylhexyl, decyl, dodecyl, hexadecyl, octadecyl, cyclohexyl, isopropyl and t-butyl.
【0034】アルケニル基としては、例えばアリル、ブ
テニルが挙げられる。アルキニル基としては、例えばプ
ロパルギル、ブチニルが挙げられる。The alkenyl group includes, for example, allyl and butenyl. Examples of the alkynyl group include propargyl and butynyl.
【0035】R、R1、R2が芳香族基の場合は、単環又
は縮合環の芳香族基が含まれ、好ましくは炭素数が6〜
20のもの、例えばフェニル、ナフチルが挙げられる。
これらは、置換されていてもよい。When R, R 1 and R 2 are aromatic groups, they include monocyclic or condensed ring aromatic groups, and preferably have 6 to 6 carbon atoms.
20 and phenyl, naphthyl and the like.
These may be substituted.
【0036】R、R1、R2がヘテロ環基の場合は、窒
素、酸素、硫黄、セレン、テルルから選ばれる元素を少
なくとも一つ有し、かつ炭素原子を少なくとも1つ有す
る。好ましくは3乃至15員環のものであり、更に好ま
しくは3〜6員環及びその縮合環が好ましく、例えばピ
ロリジン、ピペリジン、ピリジン、テトラヒドロフラ
ン、チオフェン、オキサゾール、チアゾール、イミダゾ
ール、ベンゾチアゾール、ベンズオキサゾール、ベンズ
イミダゾール、セレナゾール、ベンゾセレナゾール、テ
ルラゾール、トリアゾール、ベンゾトリアゾール、テト
ラゾール、オキサジアゾール、チアジアゾール環が挙げ
られる。When R, R 1 and R 2 are heterocyclic groups, they have at least one element selected from nitrogen, oxygen, sulfur, selenium and tellurium and have at least one carbon atom. It is preferably a 3- to 15-membered ring, more preferably a 3- to 6-membered ring and a condensed ring thereof. For example, pyrrolidine, piperidine, pyridine, tetrahydrofuran, thiophene, oxazole, thiazole, imidazole, benzothiazole, benzoxazole, Examples include benzimidazole, selenazole, benzoselenazole, tellurazole, triazole, benzotriazole, tetrazole, oxadiazole, and thiadiazole ring.
【0037】R、R1、R2の置換基としては、例えばア
ルキル基(例えば、メチル、エチル、へキシル)、アル
コキシ基(例えば、メトキシ、エトキシ、オクチルオキ
シ)、アリール基(例えば、フェニル、ナフチル、トリ
ル)、ヘテロ環基、ヒドロキシ基、ハロゲン原子(例え
ばフッ素、塩素、臭素、沃素)、アリーロキシ基(例え
ば、フェノキシ)、アリーロキシカルボニルオキシ基
(例えばフェノキシカルボニルオキシ基)、アルキルチ
オ基(例えば、メチルチオ、ブチルチオ)、アリールチ
オ基(例えば、フェニルチオ)、アシル基(例えば、ア
セチル、プロピオニル、ブチリル、バレリル)、スルホ
ニル基(例えば、メチルスルホニル、フェニルスルホニ
ル)、アシルアミノ基(例えば、アセチルアミノ、ベン
ゾイルアミノ)、スルホニルアミノ基(例えば、メタン
スルホニルアミノ、ベンゼンスルホニルアミノ)、アシ
ロキシ基(例えば、アセトキシ、ベンゾキシ)、カルボ
キシル基、シアノ基、スルホ基、アミノ基、−SO2S
M基(Mは1価の陽イオンを示す)、−SO2SR基
(Rはアルキル基を示す)が挙げられる。Lで表される
2価の連結基としては、C,N,S及びOから選ばれる
少なくとも1種を含む原子又は原子団である。Examples of the substituent for R, R 1 and R 2 include an alkyl group (eg, methyl, ethyl, hexyl), an alkoxy group (eg, methoxy, ethoxy, octyloxy), and an aryl group (eg, phenyl, Naphthyl, tolyl), heterocyclic group, hydroxy group, halogen atom (eg, fluorine, chlorine, bromine, iodine), aryloxy group (eg, phenoxy), aryloxycarbonyloxy group (eg, phenoxycarbonyloxy group), alkylthio group (eg, , Methylthio, butylthio), arylthio groups (eg, phenylthio), acyl groups (eg, acetyl, propionyl, butyryl, valeryl), sulfonyl groups (eg, methylsulfonyl, phenylsulfonyl), acylamino groups (eg, acetylamino, benzoylamino) ), Ruhoniruamino group (e.g., methanesulfonylamino, benzenesulfonylamino), an acyloxy group (e.g., acetoxy, benzoxy), a carboxyl group, a cyano group, a sulfo group, an amino group, -SO 2 S
Examples include an M group (M represents a monovalent cation) and a —SO 2 SR group (R represents an alkyl group). The divalent linking group represented by L is an atom or an atomic group containing at least one selected from C, N, S and O.
【0038】具体的にはアルキレン基、アルケニレン
基、アルキニレン基、アリーレン基、−O−、−S−、
−NH−、−CO−、−SO2−等の単独又はこれらの
組合せからなるものである。Lは好ましくは二価の脂肪
族基又は二価の芳香族基である。Specifically, an alkylene group, alkenylene group, alkynylene group, arylene group, -O-, -S-,
-NH -, - CO -, - SO 2 - is made of a single or combination of such. L is preferably a divalent aliphatic group or a divalent aromatic group.
【0039】上記二価の脂肪族基としては例えば−(C
H2)n−(nは1〜12)、−CH2−CH=CH−C
H2−、−CH2C≡CCH2−、−CH2−1,4−シク
ロヘキシレン−CH2−、キシリレン基、などが挙げら
れる。Lの二価の芳香族基としては、例えばフェニレン
基、ナフチレン基などが挙げられる。これらの連結基
は、更にこれまで述べた置換基で置換されていてもよ
い。As the divalent aliphatic group, for example,-(C
H 2) n- (n is 1~12), - CH 2 -CH = CH-C
H 2 -, - CH 2 C≡CCH 2 -, - CH 2 -1,4- cyclohexylene -CH 2 -, xylylene group, and the like. Examples of the divalent aromatic group for L include a phenylene group and a naphthylene group. These linking groups may be further substituted with the substituents described above.
【0040】Mは陽イオンを表し、好ましくは、金属イ
オン又は有機カチオンである。金属イオンとしては、例
えばリチウムイオン、ナトリウムイオン、カリウムイオ
ンが挙げられる。有機カチオンとしては、例えばアンモ
ニウムイオン(アンモニウム、テトラメチルアンモニウ
ム、テトラブチルアンモニウム等)、ホスホニウムイオ
ン(テトラフェニルホスホニウム)、グアニジル基が挙
げられる。M represents a cation, and is preferably a metal ion or an organic cation. Examples of the metal ion include a lithium ion, a sodium ion, and a potassium ion. Examples of the organic cation include an ammonium ion (ammonium, tetramethylammonium, tetrabutylammonium, etc.), a phosphonium ion (tetraphenylphosphonium), and a guanidyl group.
【0041】一般式(1)乃至(3)で表される化合物
がポリマーである場合、その繰り返し単位として例えば
以下のものが挙げられる。When the compounds represented by the general formulas (1) to (3) are polymers, examples of the repeating unit include the following.
【0042】[0042]
【化1】 Embedded image
【0043】これらのポリマーは、ホモポリマーでもよ
いし他の共重合モノマーとのコポリマーでもよい。一般
式(1)乃至(3)で表される化合物の具体例を以下に
挙げるが、これらに限定されるものではない。These polymers may be homopolymers or copolymers with other copolymerized monomers. Specific examples of the compounds represented by the general formulas (1) to (3) are shown below, but are not limited thereto.
【0044】[0044]
【化2】 Embedded image
【0045】[0045]
【化3】 Embedded image
【0046】[0046]
【化4】 Embedded image
【0047】[0047]
【化5】 Embedded image
【0048】[0048]
【化6】 Embedded image
【0049】[0049]
【化7】 Embedded image
【0050】[0050]
【化8】 Embedded image
【0051】一般式(1)乃至(3)で表される化合物
は、特開昭54−1019号、英国特許972,211
号、Journal of Organic Chem
istry(ジャーナル オブ オーガニックケミスト
リー)53巻、396頁(1988)に記載の方法又は
それに準じた方法により合成できる。The compounds represented by the general formulas (1) to (3) are described in JP-A-54-1019 and British Patent 972,211.
No., Journal of Organic Chem
The compound can be synthesized by the method described in “Istry (Journal of Organic Chemistry)”, vol. 53, p. 396 (1988) or a method analogous thereto.
【0052】本発明においては、銀1モルに対する一般
式(1)乃至(3)で表される化合物の添加量は10-7
〜10-1モルの範囲から選ぶのが望ましい。好ましくは
10-6〜10-2モルの範囲であり、より好ましくは10
-5〜10-3モルの範囲である。一般式(1)乃至(3)
で表される化合物はハロゲン化銀乳剤を製造する工程
中、例えばハロゲン化銀粒子形成中、化学増感前或いは
後のどの段階で添加してもよいが、好ましいのは化学増
感前であり、より好ましくは粒子形成中であり、又、一
般式(1)乃至(3)で表される化合物は還元増感開始
前或いは開始後どちらの段階で添加してもよいが、還元
増感開始後に添加することが好ましい。In the present invention, the amount of the compound represented by any of formulas (1) to (3) per mol of silver is 10 -7.
It is desirable to select from the range of 10 to 10 -1 mol. Preferably it is in the range of 10 -6 to 10 -2 mol, more preferably 10 -6.
The range is -5 to 10 -3 mol. General formulas (1) to (3)
The compound represented by may be added at any stage during the process of producing a silver halide emulsion, for example, during silver halide grain formation, before or after chemical sensitization, but preferably before chemical sensitization. More preferably, grains are being formed, and the compounds represented by the general formulas (1) to (3) may be added at any stage before or after the start of reduction sensitization. It is preferred to add it later.
【0053】一般式(1)乃至(3)で表される化合物
を製造工程中に添加せしめるには、写真乳剤に添加剤を
加える場合に通常用いられる方法を適用できる。例え
ば、水溶性の化合物は適当な濃度の水溶液とし、水に不
溶又は難溶性の化合物は水と混和しうる適当な有機溶
媒、例えばアルコール類、グリコール類、ケトン類、エ
ステル類、アミド類などのうち、写真特性に悪い影響を
与えない溶媒に溶解し、溶液として添加できる。In order to add the compounds represented by the general formulas (1) to (3) during the production process, a method usually used for adding an additive to a photographic emulsion can be applied. For example, a water-soluble compound is an aqueous solution having an appropriate concentration, and a compound that is insoluble or hardly soluble in water is a suitable organic solvent that is miscible with water, such as alcohols, glycols, ketones, esters, and amides. Of these, the compound can be dissolved in a solvent that does not adversely affect photographic properties and added as a solution.
【0054】本発明においては、更に超薄平板状粒子に
ドーパントを配合することがより好ましい。本発明で用
いられる「ドーパント」とは、超薄平板状粒子を形成す
るハロゲン化銀の面心立方結晶格子構造内に含有される
銀若しくはハロゲン化物イオン以外の物質を意味する。
ドーパントの導入は、高濃度での導入及び/又は粒子核
形成前、核形成中若しくは核形成直後の導入される場
合、沈殿中の超薄平板状粒子の厚み増加に寄与するが、
超薄平板状粒子は、本発明の実施例で示すように、ドー
パントを粒子成長中に存在させて形成できる。この際、
ドーパントの導入は、粒子形成後まで遅延させ、粒子成
長の初期に割当の量導入し、好ましくはそのまま継続す
るか、超薄平板状粒子成長の後段階全体を通じて行う。
又、これらの同じドーパントは、超薄平板状粒子の厚み
の増加を完全に回避しながら、超薄平板状粒子にエピタ
キシー付着する銀塩とともに導入できることも判明し
た。In the present invention, it is more preferable to add a dopant to the ultrathin tabular grains. The "dopant" used in the present invention means a substance other than silver or halide ions contained in the face-centered cubic crystal lattice structure of silver halide forming ultrathin tabular grains.
The introduction of the dopant contributes to an increase in the thickness of the ultrathin tabular grains during precipitation when introduced at a high concentration and / or before, during or immediately after nucleation of the grains.
Ultrathin tabular grains can be formed with dopants present during grain growth, as shown in the examples of the present invention. On this occasion,
The introduction of the dopant is delayed until after the grain formation, and a quota is introduced at the beginning of the grain growth, preferably continuing as it is, or throughout the entire later stage of ultrathin tabular grain growth.
It has also been found that these same dopants can be introduced with silver salts that epitaxy adhere to the ultrathin tabular grains, while completely avoiding the increase in thickness of the ultrathin tabular grains.
【0055】本発明においては、ハロゲン化銀に有用で
あることが知られている通常のドーパントはいずれも用
いることができる。元素の周期律表内の広範囲の周期及
び族から選択される写真学的に有用なドーパントが報告
されている。本発明で用いられる周期及び族から選択さ
れるドーパントとしては、American Chem
ical Societyにより採用され、Chemi
cal and Engineering News、
1985年2月4日、第26頁に公表されている元素の
周期表に基づいている。通常のドーパントには、Fe,
Co,Ni,Ru,Rh,Pd,Re,Os,Ir,P
t,Mg,A1,Ca,Sc,Ti,V,Cr,Mn,
Cu,Zn,Ga,Ge,As,Se,Sr,Y,M
o,Zr,Nb,Cd,In,Sn,Sb,Ba,L
a,W,Au,Hg,Tl,Pb,Bi,Ce及びU等
の元素の周期表の第3〜7周期(最も一般的には第4〜
6周期)からのイオンが含まれる。ドーパントは、
(a)感度の増加、(b)高又は低照度相反則不軌の減
少、(c)コントラストの変動の増加、低下又は減少、
(d)圧力感受性の減少、(e)色素減感の減少、
(f)安定性(熱不安定性の減少を含む)の増加、
(g)最小濃度の減少及び/又は(h)最大濃度の増
加、に対し用いることができる。ある種の用途では、何
れの多価金属イオンも効果的である。In the present invention, any ordinary dopant known to be useful for silver halide can be used. Photographically useful dopants selected from a wide range of periods and groups within the periodic table of elements have been reported. As the dopant selected from the periodicity and the group used in the present invention, American Chem
Employed by Ical Society, Chemi
cal and Engineering News,
Based on the Periodic Table of the Elements published February 4, 1985, page 26. Common dopants include Fe,
Co, Ni, Ru, Rh, Pd, Re, Os, Ir, P
t, Mg, A1, Ca, Sc, Ti, V, Cr, Mn,
Cu, Zn, Ga, Ge, As, Se, Sr, Y, M
o, Zr, Nb, Cd, In, Sn, Sb, Ba, L
a, W, Au, Hg, Tl, Pb, Bi, Ce, U, etc. Periodic tables of the third to seventh periods (most commonly the fourth to seventh periods)
6 cycles). The dopant is
(A) increase in sensitivity, (b) decrease in high or low illuminance reciprocity failure, (c) increase, decrease or decrease in contrast variation,
(D) reduced pressure sensitivity, (e) reduced dye desensitization,
(F) increased stability (including reduced thermal instability);
(G) decrease in minimum density and / or (h) increase in maximum density. For certain applications, any multivalent metal ion is effective.
【0056】以下に、ハロゲン化銀にドーパントとして
組み込んだときに上記の効果の一つ以上を生じることが
できる通常のドーパントの文献例を示す。The following are literature examples of ordinary dopants that can produce one or more of the above effects when incorporated as a dopant into silver halide.
【0057】B.H.Carroll、「Iridiu
m Sensitization:A Literat
ure Review」、Photographic
Science and Engineering、第
24巻、第6号、1980年11/12月、第265〜
267頁;米国特許第1,951,933号(Hoch
stetter),同2,628,167号(De W
itt),同3,687,676号(Spence等)
及び同3,761,267号(Gilman等);同
3,890,154号(Ohkubo等);同3,90
1,711号(Iwaosa等),同3,901,71
3号(Yamasue等);同4,173,483号
(Habu等);同4,269,927号(Atwel
l),同4,413,055号(Weyde);同4,
477,561号(Menjo等),同4,581,3
27号(Habu等),同4,643,965号(Ku
bota等),同4,806,462号(Yamash
ita等);同4,828,962号(Grzesko
wiak等);同4,835,093号(Januso
nsis);同4,902,611号(Leubner
等);同4,981,780号(井上等);同4,99
7,751号(Kim);同5,057,402号(S
hiba等);同5,134,060号(Maekaw
a等);同5,153,110号(Kawai等);同
5,164,292号(Johnson等);同5,1
66,044号及び第5,204,234号(Asam
i);同5,166,045号(Wu);同5,22
9,263号(Yoshida等);同5,252,4
51号及び第5,252,530号(Bell);欧州
特許第244,184号(Komorita等);同第
488,737号及び第488,601号(Miyos
hi等);同第368,304号(Ihama等);同
第405,938号(Tashiro);同第509,
674号及び同第563,946号(Murakami
等)及び特願平2−249588号及びWO第93/2
390号(Budz)。B. H. Carroll, "Iridiu
m Sensitization: A Literat
ure Review ”, Photographic
Science and Engineering, Vol. 24, No. 6, November / December 1980, 265-265
267; U.S. Patent No. 1,951,933 (Hoch
No. 2,628,167 (De W)
itt), No. 3,687,676 (Spence, etc.)
Nos. 3,761,267 (Gilman et al.); 3,890,154 (Ohkubo et al.); 3,90
No. 1,711 (Iwaosa et al.), 3,901,71
No. 3 (Yamasue et al.); No. 4,173,483 (Habu et al.); No. 4,269,927 (Atwel)
l), No. 4,413,055 (Weyde);
477,561 (Menjo et al.), 4,581,3
No. 27 (Habu et al.) And No. 4,643,965 (Ku
No. 4,806,462 (Yamash)
No. 4,828,962 (Grzesko)
No. 4,835,093 (Januso)
No. 4,902,611 (Leubner)
No. 4,981,780 (Inoue et al.); No. 4,991
7,751 (Kim); 5,057,402 (S
No. 5,134,060 (Maekawa)
No. 5,153,110 (Kawai et al.); 5,164,292 (Johnson et al.); 5,1
Nos. 66,044 and 5,204,234 (Asam
i); 5,166,045 (Wu); 5,22
9,263 (Yoshida et al.); 5,252,4
Nos. 51 and 5,252,530 (Bell); European Patent Nos. 244,184 (Komorita et al.); And 488,737 and 488,601 (Miyos)
No. 368,304 (Ihama et al.); No. 405,938 (Tashiro); No. 509,
Nos. 674 and 563,946 (Murakami
Etc.) and Japanese Patent Application No. 2-249588 and WO 93/2
No. 390 (Budz).
【0058】ドーパントとして用いられる金属が沈殿中
に配位錯体、特にテトラ−及びヘキサ−配位錯体の形で
存在するとき、金属イオンと配位リガンドの両方を粒子
内に吸蔵できる。同4,847,191号(Grzes
kowiak)、同4,933,272号、第4,98
1,781号及び第5,037,732号(McDug
le等)、同937,180号(Marchetti
等)、同4,945,035号(Keert等)、同
5,112,732号(Hayashi)、欧州特許第
509,674号(Murakami等)、同513,
738号(Ohya等)、WO第91/10166号
(Janusonis)、WO第92/16876号
(Beavers)、ドイツ国DD第298,320号
(Pietsch等)により示されているように、ハ
ロ、アクオ、シアノ、シアネート、フルミネート、チオ
シアネート、セレノシアネート、テルロシアネート、ニ
トロシル、チオニトロシル、アジド、オキソ、カルボニ
ル及びエチレンジアミン四酢酸(EDTA)リガンドが
開示され、ある場合には、リガンドによる乳剤特性の改
良が認められる。同5,360,712号(Olm等)
は、有機リガンド含有ヘキサ配位錯体を開示し、一方、
同4,092,171号(Bigelow)は、Pt及
びPdテトラ配位錯体における有機リガンドを開示して
いる。超薄平板状粒子にドーパントを組み込んで相反則
不軌を減少させることが具体的に意図される。イリジウ
ムは、相反則不軌を減少するのに好ましいドーパントで
ある。Carroll、Iwaosa等、Habu等、
Grzeskowiak等、Kim、Maekawa
等、Johnson等、Asami、Yoshida
等、Bell、Miyoshi等、Tashiroの開
示及び欧州特許第509,674号(Murakami
等)の開示が代表的である。これらの開示は、ハロゲン
化銀沈殿中に単にドーパントを組み込むことにより本発
明の乳剤に適用できる。RD、第367巻、1994年
11月、アイテム36736には、浅い電子トラップ
(SET)ドーパントを選定する基準のわかりやすい説
明がある。特定の好ましい態様では、ドーパントとして
下記一般式(4)を満足するヘキサ配位錯体を使用する
ことが意図される。When the metal used as dopant is present in the precipitate in the form of a coordination complex, in particular a tetra- and hexa-coordination complex, both metal ions and coordinating ligands can be absorbed in the particles. 4,847,191 (Grzes
No. 4,933,272, No. 4,984.
No. 1,781 and 5,037,732 (McDug
le, etc.), No. 937,180 (Marchetti)
Nos. 4,945,035 (Keert et al.), 5,112,732 (Hayashi), and EP 509,674 (Murakami et al.), 513,
No. 738 (Ohya et al.), WO 91/10166 (Janusonis), WO 92/16876 (Beavers), Halo, Aquo as indicated by DD 298,320 (Pietsch et al.), Germany. , Cyano, cyanate, flumate, thiocyanate, selenocyanate, tellurocyanate, nitrosyl, thionitrosyl, azide, oxo, carbonyl and ethylenediaminetetraacetic acid (EDTA) ligands, wherein in some cases the improvement of emulsion properties by the ligands is disclosed. Is recognized. 5,360,712 (Olm, etc.)
Discloses hexacoordination complexes containing organic ligands, while
U.S. Pat. No. 4,092,171 (Biglow) discloses organic ligands in Pt and Pd tetracoordination complexes. It is specifically contemplated to incorporate dopants into ultrathin tabular grains to reduce reciprocity failure. Iridium is a preferred dopant for reducing reciprocity failure. Carroll, Iwaosa, etc., Habu, etc.,
Grzekowiak et al., Kim, Maekawa
Etc., Johnson et al., Asami, Yoshida
Et al., Bell, Miyoshi et al., Tashiro's disclosure and EP 509,674 (Murakami).
Etc.) are representative. These disclosures are applicable to the emulsions of the invention by simply incorporating the dopant into the silver halide precipitate. Item 36736, RD, Vol. 367, November 1994, provides a straightforward description of the criteria for selecting shallow electron trap (SET) dopants. In certain preferred embodiments, it is contemplated to use a hexa-coordination complex satisfying the following general formula (4) as a dopant.
【0059】一般式(4) 〔ML6〕n 式中、Mは充満フロンティア軌道多価金属イオン、好ま
しくはFe+2,Ru+2,Os+2,Co+3,Rh+3,Ir
+3,Pd+4又はPt+4であり、L6は独立して選択する
ことができる6個の配位錯体リガンドを表すが、但し、
リガンドの少なくとも4個はアニオンリガンドであり、
リガンドの少なくとも1個(好ましくは少なくとも3個
及び最適には少なくとも4個)はいずれのハロゲン化物
リガンドよりも電気的陰性が高い。そしてnは−2、−
3又は−4である。浅い電子トラップを提供することが
できるドーパントの具体例を以下に示す: SET−1 〔Fe(CN)6〕−4 SET−2 〔Ru(CN)6〕-4 SET−3 〔Os(CN)6〕-4 SET−4 〔Rh(CN)6〕-3 SET−5 〔Ir(CN)6〕-3 SET−6 〔Fe(ピラジン)(CN)5〕-4 SET−7 〔Ru Cl(CN)5〕-4 SET−8 〔Os Br(CN)5〕-4 SET−9 〔Rh F(CN)5〕-3 SET−10 〔Ir Br(CN)5〕-3 SET−11 〔Fe CO(CN)5〕-3 SET−12 〔Ru F2(CN)4〕-4 SET−13 〔Os Cl2(CN)4〕-4 SET−14 〔Rh I2(CN)4〕-3 SET−15 〔Ir Br2(CN)4〕-3 SET−16 〔Ru(CN)5(OCN)〕-4 SET−17 〔Ru(CN)5(N3)〕-4 SET−18 〔Os(CN)5(SCN)〕-4 SET−19 〔Rh(CN)5(SeCN)〕-3 SET−20 〔Ir(CN)5(HOH)〕-2 SET−21 〔Fe(CN)3Cl3〕-4 SET−22 〔Ru(CO)2(CN)4〕-2 SET−23 〔Os(CN)Cl5〕-4 SET−24 〔Co(CN)6〕-3 SET−25 〔Ir(CN)4(オキサレート)〕-3 SET−26 〔In(NCS)6〕-3 SET−27 〔Ga(NCS)6〕-3 更に、米国特許第5,024,931号(Evans
等)に開示されているように、オリゴマー配位錯体を用
いてスピード増加することも意図される。ドーパント
は、通常の濃度(ここで、濃度とは、平板状粒子におけ
る銀及び突起部における銀の両方を含めた総銀を基準と
した濃度である)で有効である。一般的に、浅い電子ト
ラップ形成ドーパントを、銀1モル当たり少なくとも1
×10-6モル〜溶解限界(典型的には銀1モル当たり約
5×10-4モル以下の濃度)で取り込むことが意図され
る。好ましい濃度は、銀1モル当たり約10-5〜10-4
モルの範囲である。Formula (4) [ML 6 ] n In the formula, M is a charged frontier orbital polyvalent metal ion, preferably Fe +2 , Ru +2 , Os +2 , Co +3 , Rh +3 , Ir.
+3 , Pd +4 or Pt +4 , wherein L 6 represents six independently selectable coordination complex ligands, with the proviso that
At least four of the ligands are anionic ligands;
At least one (preferably at least three and optimally at least four) of the ligands is more electronegative than any halide ligand. And n is -2,-
3 or -4. Specific examples of dopants that can provide a shallow electron trap are: SET-1 [Fe (CN) 6 ] -4 SET-2 [Ru (CN) 6 ] -4 SET-3 [Os (CN) 6 ] -4 SET-4 [Rh (CN) 6 ] -3 SET-5 [Ir (CN) 6 ] -3 SET-6 [Fe (pyrazine) (CN) 5 ] -4 SET-7 [RuCl ( CN) 5 ] -4 SET-8 [OsBr (CN) 5 ] -4 SET-9 [Rh F (CN) 5 ] -3 SET-10 [IrBr (CN) 5 ] -3 SET-11 [Fe CO (CN) 5] -3 SET-12 [Ru F 2 (CN) 4] -4 SET-13 [Os Cl 2 (CN) 4] -4 SET-14 [Rh I 2 (CN) 4] -3 SET-15 [Ir Br 2 (CN) 4] -3 SET-16 [Ru (CN) 5 (OCN)] -4 SET-1 [Ru (CN) 5 (N 3 ) ] -4 SET-18 [Os (CN) 5 (SCN)] -4 SET-19 [Rh (CN) 5 (SeCN)] -3 SET-20 [Ir (CN ) 5 (HOH)] -2 SET-21 [Fe (CN) 3 Cl 3 ] -4 SET-22 [Ru (CO) 2 (CN) 4 ] -2 SET-23 [Os (CN) Cl 5 ] - 4 SET-24 [Co (CN) 6 ] -3 SET-25 [Ir (CN) 4 (oxalate)] -3 SET-26 [In (NCS) 6 ] -3 SET-27 [Ga (NCS) 6 ] -3 Further, US Pat. No. 5,024,931 (Evans
It is also contemplated to use an oligomeric coordination complex to increase speed, as disclosed in US Pat. The dopant is effective at normal concentrations (where the concentration is a concentration based on total silver including both silver in tabular grains and silver in protrusions). Generally, the shallow electron trap-forming dopant should be added at least one mole per silver mole.
It is intended to be incorporated at from × 10 -6 mole to the solubility limit (typically a concentration of about 5 × 10 -4 mole or less per mole of silver). Preferred concentrations are from about 10 -5 to 10 -4 per silver mole.
Range of moles.
【0060】本発明の乳剤は、粒子表面に潜像形成性化
学増感部位を有し、該潜像形成性化学増感部位がエピタ
キシャル配置された少なくとも1種のハロゲン化銀突起
部を有する平板状粒子を含むことが好ましい。即ち、平
板状粒子に、硫黄に代表されるカルコゲン増感及び/又
は金増感等の化学増感が、エピタキシャル配置されたハ
ロゲン化銀突起部に少なくとも施されていることを意味
する。The emulsion of the present invention has a tabular surface having at least one silver halide projection having a latent image forming chemical sensitized site on the grain surface and the latent image forming chemical sensitized site being epitaxially arranged. It is preferable that the particles include shaped particles. That is, it means that the tabular grains have been subjected to at least chemical sensitization such as chalcogen sensitization represented by sulfur and / or gold sensitization to the epitaxially arranged silver halide projections.
【0061】基盤となる平板状粒子(以下「ホスト平板
粒子」と呼ぶこともある)の選択された部位にハロゲン
化銀突起部をエピタキシャル配置することにより、像様
露光での光子吸収により放出された伝導帯電子の増感部
位への競争が減少され、よって感度が向上することが一
般的に開示されている。米国特許第4,435,501
号では、ホスト平板粒子の表面の選択された部位に銀塩
をエピタキシャル付着することによる感度の向上を開示
している。該米国特許では感度の増加は銀塩のエピタキ
シャル付着をホスト平板粒子の表面積の小部分に制限し
たためとしている。即ち、超薄平板状粒子の主平面の限
定された部分へのエピタキシャル配置は、主平面の全部
又はほとんどを覆うエピタキシャル配置よりも効率的で
あり、更に好ましいのは、ホスト平板粒子のエッジに実
質的に制限され、且つ主平面への被覆量が限定されるエ
ピタキシャル配置であり、更に効率的で好ましいのは、
ホスト平板粒子のコーナー或いはその近傍又は他の別個
の部位に制限されるエピタキシャル配置である。ホスト
平板粒子それ自体の主平面のコーナーの間隔は、光電子
競争をほぼ最大感度が実現できる程度に十分減少させ
る。前記米国特許第4,435,501号では、エピタ
キシャル付着速度を遅くすることにより、ホスト平板粒
子へのエピタキシャル配置部位の数を減少できることが
開示されている。The silver halide projections are epitaxially arranged on selected portions of the base tabular grains (hereinafter sometimes referred to as “host tabular grains”), so that they are emitted by photon absorption in imagewise exposure. It is generally disclosed that conduction band electrons competition for sensitized sites is reduced, thereby improving sensitivity. U.S. Pat. No. 4,435,501
Discloses improvement in sensitivity by epitaxially depositing a silver salt on selected sites on the surface of host tabular grains. The US patent states that the increase in sensitivity is due to limiting the epitaxial deposition of the silver salt to a small fraction of the surface area of the host tabular grains. In other words, the epitaxial arrangement of the ultrathin tabular grains on a limited portion of the main plane is more efficient than the epitaxial arrangement covering all or most of the main plane, and more preferably, substantially at the edge of the host tabular grain. Is epitaxially limited, and the amount of coating on the main plane is limited, and more efficient and preferable are:
This is an epitaxial arrangement limited to the corner of the host tabular grain, its vicinity, or another distinct site. The spacing of the corners of the main plane of the host tabular grains themselves reduces photoelectron competition sufficiently to achieve near maximum sensitivity. U.S. Pat. No. 4,435,501 discloses that reducing the rate of epitaxial deposition can reduce the number of sites of epitaxial placement on host tabular grains.
【0062】よって、本発明においても、ホスト平板粒
子の表面積にエピタキシャル配置されるハロゲン化銀突
起部は、ホスト平板粒子の表面積の小部分に制限するこ
とが好ましく、コーナー又はその近傍に制限されること
が特に好ましい。具体的には50%未満であることが好
ましく、30%未満であることが更に好ましい。又、エ
ピタキシャル配置されるハロゲン化銀突起部の銀量は、
ホスト平板粒子の銀量に対して0.3〜25%であるこ
とが好ましく、0.5〜15%であることが更に好まし
い。Therefore, also in the present invention, the silver halide projections epitaxially arranged on the surface area of the host tabular grain are preferably limited to a small portion of the surface area of the host tabular grain, and are limited to the corner or its vicinity. Is particularly preferred. Specifically, it is preferably less than 50%, and more preferably less than 30%. In addition, the silver amount of the silver halide protrusions arranged epitaxially is:
It is preferably from 0.3 to 25%, more preferably from 0.5 to 15%, based on the silver content of the host tabular grains.
【0063】本発明の最も好ましい態様の1つとして
は、エピタキシャル配置されるハロゲン化銀突起部がホ
スト平板粒子のコーナー又はその近傍の制限された位置
に形成されることが好ましく、これを達成するための方
法としては公知の方法を適用することができる。前記米
国特許第4,435,501号では、分光増感色素やア
ミノアザインデン類を部位指向体(site dire
ctor)として吸着させる方法が開示されており、本
発明においても好ましく適用できる。In one of the most preferred embodiments of the present invention, it is preferable that the silver halide projections to be epitaxially arranged are formed at the corners of the host tabular grains or at restricted positions near the corners, and this is achieved. As a method for this, a known method can be applied. In the above-mentioned U.S. Pat. No. 4,435,501, a spectral sensitizing dye or an aminoazaindene is used as a site director.
A method of adsorbing as ctrl) is disclosed and can be preferably applied in the present invention.
【0064】ホスト平板粒子である超薄平板状粒子の構
造的崩壊を回避するために、エピタキシャル配置される
ハロゲン化銀突起部は、その総溶解度がホスト平板粒子
を形成するハロゲン化銀の総溶解度よりも高いことが好
ましい。よって、エピタキシャル配置されるハロゲン化
銀突起部は、具体的には塩化銀であることが好ましい。In order to avoid structural collapse of ultrathin tabular grains as host tabular grains, the total solubility of silver halide projections arranged epitaxially is determined by the total solubility of silver halide forming host tabular grains. It is preferably higher than that. Therefore, it is preferable that the silver halide projections to be epitaxially arranged are specifically silver chloride.
【0065】塩化銀は、臭化銀のように面心立方格子構
造を形成するので、エピタキシャル付着を容易にする。
超薄平板状粒子の構造的一体性を保持するために、エピ
タキシャル付着は、超薄平板状粒子を形成するハロゲン
化物の溶解性を制限する条件下で行われることが好まし
い。しかし、エピタキシャル配置されたハロゲン化銀突
起部のハロゲン化物が、ホスト平板粒子からのものであ
ることが意図される場合がある。即ち、少量の臭化物及
び場合によっては沃化物を含有する塩化銀突起部が具体
的に意図される。Silver chloride facilitates epitaxial deposition because it forms a face-centered cubic lattice structure like silver bromide.
In order to preserve the structural integrity of the ultrathin tabular grains, the epitaxial deposition is preferably performed under conditions that limit the solubility of the halide forming the ultrathin tabular grains. However, in some cases, it is intended that the halide of the epitaxially arranged silver halide projection is from a host tabular grain. That is, silver chloride protrusions containing a small amount of bromide and optionally iodide are specifically contemplated.
【0066】本発明の乳剤は、硫黄に代表されるカルコ
ゲン及び/又は金による化学増感が施されていることが
好ましい。エピタキシャル配置されたハロゲン化銀突起
部を有するホスト平板粒子の場合は、それ自体で硫黄及
び/又は金を用いた実質的に最適な化学増感により得ら
れるのに匹敵する程度にまで感度を増加させるが、その
上にハロゲン化銀をエピタキシャル配置した平板状粒子
に化学増感が施されると、更に感度が増加するため好ま
しい。The emulsion of the present invention is preferably subjected to chemical sensitization with chalcogen represented by sulfur and / or gold. In the case of host tabular grains having silver halide projections arranged epitaxially, the sensitivity is increased to an extent comparable to that obtained by substantially optimal chemical sensitization using sulfur and / or gold by itself. However, it is preferable that the tabular grains on which silver halide is epitaxially arranged are subjected to chemical sensitization because sensitivity is further increased.
【0067】化学増感法は公知の方法を適用でき、例え
ばRD、1989年12月、アイテム308119、セ
クションIII「化学増感」に記載されている。化学増感
剤も、公知の種々のものを適用できる。特にエピタキシ
ャル配置されたハロゲン化銀突起部を有する平板状粒子
の場合は、硫黄増感剤を、ミドルカルコゲン(典型的に
は硫黄)及び貴金属(典型的には金)化学増感剤と組み
合わせて用いることが好ましい。意図する硫黄増感剤に
は、米国特許第3,271,157号、同3,574,
628号及び同3,737,313号で説明されている
チオエーテル類が含まれる。好ましい硫黄増感剤は、米
国特許第2,222,264号、同2,448,534
号及び同3,320,069号で説明されているチオシ
アネート類である。好ましい種類のミドルカルコゲン増
感剤は、米国特許第4,749,646号及び同4,8
10,626号に開示されている種類のテトラ置換ミド
ルカルコゲン尿素である。A known method can be applied to the chemical sensitization method, and is described in, for example, RD, December 1989, Item 308119, Section III “Chemical sensitization”. Various known chemical sensitizers can be applied. Particularly in the case of tabular grains having silver halide protrusions arranged epitaxially, the sulfur sensitizer is combined with a middle chalcogen (typically sulfur) and a noble metal (typically gold) chemical sensitizer. Preferably, it is used. The intended sulfur sensitizers include U.S. Patent Nos. 3,271,157 and 3,574.
Thioethers described in US Pat. Nos. 628 and 3,737,313. Preferred sulfur sensitizers are described in U.S. Patent Nos. 2,222,264 and 2,448,534.
And thiocyanates described in JP-A-3,320,069. Preferred types of middle chalcogen sensitizers are described in U.S. Pat. Nos. 4,749,646 and 4,8
No. 10,626 are tetra-substituted middle chalcogen ureas.
【0068】本発明の乳剤は、特定波長域の光に対する
感度を増加させるために、分光増感が施されていること
が好ましい。分光増感法、分光増感色素は、公知の種々
のものを適用でき、例えばRD、1989年12月、ア
イテム308119、セクションIV「分光増感及び減
感」に記載されている。エピタキシャル配置されたハロ
ゲン化銀突起部を有する平板状粒子の場合は、前述した
ようにエピタキシャル付着時に部位指向体として既に分
光増感色素が吸着されている場合が多いため、特に有利
である。この場合、エピタキシャル付着時に添加する分
光増感色素は適宜選択して使用することが好ましく、必
要に応じて増感工程で更に分光増感色素を追加すること
も可能である。The emulsion of the present invention is preferably subjected to spectral sensitization in order to increase sensitivity to light in a specific wavelength range. Various known spectral sensitizing methods and spectral sensitizing dyes can be applied, and are described, for example, in RD, December 1989, Item 308119, Section IV, “Spectral Sensitization and Desensitization”. In the case of tabular grains having silver halide projections arranged epitaxially, a spectral sensitizing dye is often already adsorbed as a site directing substance at the time of epitaxial deposition as described above, which is particularly advantageous. In this case, it is preferable to appropriately select and use the spectral sensitizing dye to be added at the time of epitaxial deposition, and it is also possible to further add a spectral sensitizing dye in the sensitizing step as needed.
【0069】本発明の乳剤は、更にいずれかの通常の方
法により、種々の写真感光材料に使用することができ
る。重要な1つの態様として、本発明の乳剤は、少なく
とも2層のハロゲン化銀乳剤層を有する多層写真感光材
料の使用に適している。例えばカラーネガフィルム、カ
ラーリバーサルフィルムのような多層写真感光材料であ
る場合、上層側に塗設したハロゲン化銀乳剤層は下層側
のそれより短い波長の光に感光する場合が多い。本発明
の乳剤は下層で感光することを意図しているマイナスブ
ルー光の散乱が大きく減少し透過性に優れており、上層
のハロゲン化銀乳剤層にも好ましく適用できる。The emulsion of the present invention can be used in various photographic materials by any conventional method. As one important aspect, the emulsion of the present invention is suitable for use in a multilayer photographic material having at least two silver halide emulsion layers. For example, in the case of a multilayer photographic light-sensitive material such as a color negative film or a color reversal film, the silver halide emulsion layer coated on the upper layer is often sensitive to light having a shorter wavelength than that of the lower layer. The emulsion of the present invention has excellent transparency because the scattering of minus blue light intended to be exposed in the lower layer is greatly reduced and the emulsion can be preferably applied to the upper silver halide emulsion layer.
【0070】[0070]
【実施例】以下、実施例を挙げて本発明を詳細に説明す
るが、本発明の態様はこれに限定されない。尚、ハロゲ
ン化物イオン濃度は、銀に対するモル%(M%)で表
す。EXAMPLES The present invention will be described below in detail with reference to examples, but embodiments of the present invention are not limited thereto. Incidentally, the halide ion concentration is represented by mol% (M%) based on silver.
【0071】実施例1 〈乳剤A〉 (薄い平板状粒子 比較例)攪拌機を備えた容器に、石
灰処理骨ゼラチン3.75g、KBr4.76g、消泡
剤、及び39℃でpHを1.8に調整するのに十分な量
の硫酸を含有する、水6リットルを入れたAgNO3溶
液とハロゲン化物(KBrとKIをそれぞれ98.5M
%及び1.5M%)溶液(両方2.5M)とを、ヨウ臭
化銀0.01335モルを生成するのに十分な量でバラ
ンスをとり、同時に添加することにより達成された核形
成中、pBrとpHは、最初に反応器内溶液で設定され
た値にほぼ維持された。核形成に続いて、温度を9分間
で54℃に上昇させた。反応器とその内容物とを、この
温度で9分間保持した後、石灰処理骨ゼラチン100g
を水1.5リットルに溶解した溶液を54℃で反応器に
添加した。次に、pHを5.90に上昇させ、1M K
Br溶液を反応器に添加した。核形成から24.5分
後、成長段階が始まり、その間に2.5M AgN
O3、2.8M KBr及びAgI(Lippman
n)の0.148M懸濁液を、(a)成長しているハロ
ゲン化銀結晶中のヨウ化物レベルを4.125M%に均
一に維持すること、及び(b)ヨウ臭化銀が0.848
モル生成するまで、反応器内pBrを、核形成と成長の
始まる前に上記したKBrの添加により得られた値に維
持するように比例させて添加した(53.33分間、一
定流量)。その後、1M KBrを添加して過剰Br-
濃度を調整し、pBrが2.20になるまで添加を行っ
た。続いて、2.5M AgNO3、2.8M KBr
及びAgI(Lippmann)の0.148M懸濁液
の流入を再開した(添加流量を加速し、セグメント初期
流量:セグメント最終流量=1:12.6)。又、添加
は反応器内のpBrが2.20を維持するように2.8
M KBr及びAgI(Lippmann)の0.14
8M懸濁液の流量を調節しながら行った。その結果、ヨ
ウ臭化銀が合計19.5モル(4.125M%I)生成
した。AgNO3、AgI及びKBrの添加が完了した
とき、生じた乳剤を凝集洗浄し、pHとpBrをそれぞ
れ保存値6と2.5に調整した。得られた乳剤を、前記
粒子解析法により調査した。総粒子投影面積の99.5
%を超える割合を平板状粒子が占めていた。又この平板
状粒子は(111)主面を有していた。この乳剤の平均
ECDは1.88μmであり、それらのCOVは32%
であった。飽和被覆量に必要とされる1,1′−ジエチ
ル−2,2′−シアニン色素のレベルを測定し、この色
素の溶液吸収係数が77,300リットル/モル-cmで
あり、1モル当たりの部位面積が0.566nm2であ
ることを用いて、表面積についての式を解いた。色素吸
着測定から求めた乳剤粒子の平均厚さは、0.140μ
mであった。又平均臭化銀含有率は、95.9mol%
であった。Example 1 <Emulsion A> (Comparative Example of Thin Tabular Grains) In a vessel equipped with a stirrer, 3.75 g of lime-processed bone gelatin, 4.76 g of KBr, an antifoaming agent, and a pH of 1.8 at 39 ° C. AgNO 3 solution containing 6 liters of water and halide (KBR and KI each 98.5 M each containing sufficient amount of sulfuric acid to adjust to
% And 1.5M%) solution (both 2.5M) in a quantity sufficient to produce 0.01335 moles of silver iodobromide during nucleation achieved by simultaneous addition, pBr and pH were almost maintained at the values initially set in the solution in the reactor. Following nucleation, the temperature was increased to 54 ° C for 9 minutes. After holding the reactor and its contents at this temperature for 9 minutes, 100 g of lime-processed bone gelatin
In 1.5 liters of water was added to the reactor at 54 ° C. Next, the pH was raised to 5.90 and 1M K
The Br solution was added to the reactor. 24.5 minutes after nucleation, the growth phase begins, during which 2.5 M AgN
O 3 , 2.8 M KBr and AgI (Lippman
The 0.148M suspension of n) was prepared by (a) maintaining a uniform iodide level in the growing silver halide crystals of 4.125M%, and (b) 0.1% silver iodobromide. 848
Until the moles were formed, pBr in the reactor was added proportionally (53.33 minutes, constant flow) to maintain the value obtained by the addition of KBr described above before the onset of nucleation and growth. Thereafter, 1M KBr was added to add excess Br −
The concentration was adjusted and the addition was carried out until the pBr reached 2.20. Subsequently, 2.5M AgNO 3 , 2.8M KBr
And the flow of 0.148M suspension of AgI (Lippmmann) was resumed (additional flow was accelerated, segment initial flow: segment final flow = 1: 12.6). Also, the addition was performed so that pBr in the reactor was maintained at 2.20.
0.14 of M KBr and AgI (Lippmann)
This was performed while adjusting the flow rate of the 8M suspension. As a result, a total of 19.5 mol (4.125 M% I) of silver iodobromide was produced. When the addition of AgNO 3 , AgI and KBr was completed, the resulting emulsion was coagulated and washed, and the pH and pBr were adjusted to storage values of 6 and 2.5, respectively. The obtained emulsion was examined by the above-mentioned grain analysis method. 99.5 of total grain projected area
% Were tabular grains. The tabular grains had a (111) major surface. The average ECD of this emulsion is 1.88 μm and their COV is 32%
Met. The level of 1,1'-diethyl-2,2'-cyanine dye required for saturated coverage was determined and the solution absorption coefficient of this dye was 77,300 l / mol- cm , The equation for surface area was solved using the site area of 0.566 nm 2 . The average thickness of the emulsion grains determined from the dye adsorption measurement was 0.140 μm.
m. The average silver bromide content was 95.9 mol%
Met.
【0072】〈乳剤B〉 (超薄平板状粒子 比較例)攪拌機を備えた容器に、石
灰処理骨ゼラチン3.75g、KBr4.76g、消泡
剤、及び39℃でpHを1.8に調整するのに十分な量
の硫酸を含有する、水6リットルを入れた。AgNO3
溶液とハロゲン化物(KBrとKIをそれぞれ98.5
M%及び1.5M%)溶液(両方2.5M)とを、ヨウ
臭化銀0.01335モルを生成するのに十分な量でバ
ランスをとり、同時に添加することにより達成された核
形成中、pBrとpHは、最初に反応器内溶液で設定さ
れた値にほぼ維持された。核形成に続いて、Oxone
(商標)(2KHSO5・KHSO4・K2SO4 Ald
rich製)128mgを水20mlに溶解した溶液を
添加することにより反応器内ゼラチンを迅速に酸化し、
温度を9分間で54℃に上昇させた。反応器とその内容
物とを、この温度で9分間保持した後、メチオニン酸化
石灰処理骨ゼラチン100gを水1.5リットルに溶解
した溶液を54℃で反応器に添加した。次に、pHを
5.90に上昇させ、1M KBr 122.5mlを
反応器に添加した。核形成から24.5分後、成長段階
が始まり、その間に2.5M AgNO3、2.8M
KBr及びAgI(Lippmann)の0.148M
懸濁液を、(a)成長しているハロゲン化銀結晶中のヨ
ウ化物レベルを4.125M%に均一に維持すること、
及び(b)ヨウ臭化銀が0.848モル生成するまで、
反応器内pBrを、核形成と成長の始まる前に上記した
KBrの添加により得られた値に維持するように比例さ
せて添加した(53.33分間、一定流量)。その後、
1M KBr溶液を添加して過剰Br-濃度を増加さ
せ、pBrが1.28になるまで添加を行った。続い
て、2.5M AgNO3、2.8M KBr及びAg
I(Lippmann)の0.148M懸濁液の流入を
再開した(添加流量を加速し、セグメント初期流量:セ
グメント最終流量=1:12.6)。又、添加は反応器
内のpBrが1.28を維持するように2.8M KB
r及びAgI(Lippmann)の0.148M懸濁
液の流量を調節しながら行った。その結果、ヨウ臭化銀
が合計9モル(4.125M%I)生成した。AgNO
3、AgI及びKBrの添加が完了したとき、生じた乳
剤を凝集洗浄し、pHとpBrをそれぞれ保存値6と
2.5に調整した。得られた乳剤を、乳剤Aと同様に調
査した。総粒子投影面積の99.5%を超える割合が平
板状粒子により占められていた。又この平板状粒子は
(111)主面を有していた。乳剤粒子の平均ECDは
1.91μmであり、それらのCOVは37%であっ
た。平板状粒子が、存在する粒子のほぼ全てを占めてい
るので、平均粒子厚さを、色素吸着法を用いて測定し
た。乳剤Aについて記載したのと同様にして色素吸着測
定から求めた乳剤粒子の平均厚さ値は0.063μmで
あった。又平均臭化銀含有率は、95.8mol%であ
った。<Emulsion B> (Comparative example of ultrathin tabular grains) In a vessel equipped with a stirrer, 3.75 g of lime-processed bone gelatin, 4.76 g of KBr, an antifoaming agent, and adjusted to pH 1.8 at 39 ° C. 6 liters of water, containing a sufficient amount of sulfuric acid to do so. AgNO 3
Solution and halide (KBR and KI each 98.5
M% and 1.5 M%) solutions (both 2.5 M) in a quantity sufficient to produce 0.01335 moles of silver iodobromide during nucleation achieved by simultaneous addition. , PBr and pH were almost maintained at the values initially set in the solution in the reactor. Following nucleation, Oxone
(Trademark) (2KHSO 5 · KHSO 4 · K 2 SO 4 Ald
Rich) (128 g) was added to a solution prepared by dissolving 128 mg in water (20 ml) to rapidly oxidize gelatin in the reactor.
The temperature was raised to 54 ° C. for 9 minutes. After holding the reactor and its contents at this temperature for 9 minutes, a solution of 100 g of methionine oxidized lime-processed bone gelatin in 1.5 l of water was added to the reactor at 54 ° C. Next, the pH was raised to 5.90 and 122.5 ml of 1 M KBr was added to the reactor. 24.5 minutes after nucleation, the growth phase begins, during which 2.5M AgNO 3 , 2.8M
0.148M of KBr and AgI (Lippmmann)
Suspending the suspension, (a) maintaining the iodide level in the growing silver halide crystals uniform at 4.125 M%;
And (b) until 0.848 moles of silver iodobromide are formed,
The pBr in the reactor was added proportionately (53.33 minutes, constant flow) to maintain the value obtained by the addition of KBr before the onset of nucleation and growth. afterwards,
The excess Br - concentration was increased by addition of a 1 M KBr solution and the addition was carried out until the pBr was 1.28. Subsequently, 2.5 M AgNO 3 , 2.8 M KBr and Ag
The flow of the 0.148 M suspension of I (Lippmann) was resumed (additional flow was accelerated, segment initial flow: segment final flow = 1: 12.6). Further, the addition was performed so that the pBr in the reactor was maintained at 1.28, and 2.8 M KB was added.
This was performed while controlling the flow rate of the 0.148 M suspension of r and AgI (Lippmmann). As a result, a total of 9 mol (4.125 M% I) of silver iodobromide was produced. AgNO
3. When the addition of AgI and KBr was completed, the resulting emulsion was coagulated and washed to adjust the pH and pBr to storage values of 6 and 2.5, respectively. The resulting emulsion was examined in the same manner as Emulsion A. Tabular grains accounted for more than 99.5% of total grain projected area. The tabular grains had a (111) major surface. The average ECD of the emulsion grains was 1.91 μm and their COV was 37%. Since tabular grains account for almost all of the grains present, the average grain thickness was measured using a dye adsorption method. The average thickness of the emulsion grains as determined by dye adsorption measurement in the same manner as described for Emulsion A was 0.063 μm. The average silver bromide content was 95.8 mol%.
【0073】〈乳剤C〉 (薄い平板状粒子+表面還元増感 比較例)下記のよう
に変更した以外は乳剤Aと同様にして調製した。<Emulsion C> (Thin Tabular Grains + Surface Reduction Sensitization Comparative Example) An emulsion E was prepared in the same manner as Emulsion A, except that the following changes were made.
【0074】粒子形成終了後、二酸化チオ尿素を銀1m
ol当たり1×10-5mol添加した。After the formation of the particles, thiourea dioxide was added to 1 m of silver.
1 × 10 −5 mol was added per ol.
【0075】〈乳剤D〉 (薄い平板状粒子+表面還元増感+チオスルホン酸ナト
リウム添加 比較例)下記のように変更した以外は乳剤
Aと同様にして調製した。<Emulsion D> (Thin tabular grains + surface reduction sensitization + addition of sodium thiosulfonate Comparative Example) Emulsion D was prepared in the same manner as Emulsion A, except that the following changes were made.
【0076】粒子形成終了後、二酸化チオ尿素を銀1m
ol当たり1×10-5mol、エチルチオスルホン酸ナ
トリウムを銀1mol当たり3×10-5mol添加し
た。After the completion of the grain formation, thiourea dioxide was added to 1 m of silver.
1 × 10 −5 mol per mol and sodium ethylthiosulfonate were added at 3 × 10 −5 mol per mol of silver.
【0077】〈乳剤E〉 (薄い平板状粒子+内部還元増感 比較例)下記のよう
に変更した以外は乳剤Aと同様にして調製した。<Emulsion E> (Thin tabular grains + internal reduction sensitization Comparative Example) Emulsion E was prepared in the same manner as Emulsion A, except that the following changes were made.
【0078】核形成から24.5分後、二酸化チオ尿素
を銀1mol当たり1×10-5mol添加した。After 24.5 minutes from the nucleation, 1 × 10 −5 mol of thiourea dioxide was added per 1 mol of silver.
【0079】〈乳剤F〉 (薄い平板状粒子+内部還元増感+チオスルホン酸ナト
リウム添加 比較例)下記のように変更した以外は乳剤
Aと同様にして調製した。<Emulsion F> (Thin tabular grains + internal reduction sensitization + addition of sodium thiosulfonate Comparative Example) Emulsion F was prepared in the same manner as Emulsion A, except that the following changes were made.
【0080】核形成から24.5分後、二酸化チオ尿素
を銀1mol当たり1×10-5mol添加し、添加銀量
の80%消費した段階で、エチルチオスルホン酸ナトリ
ウムを銀1mol当たり3×10-5mol添加した。After 24.5 minutes from the nucleation, 1 × 10 −5 mol of thiourea dioxide was added per 1 mol of silver, and at the stage when 80% of the added silver was consumed, sodium ethylthiosulfonate was added at 3 × 10 5 mol per 1 mol of silver. 10 -5 mol was added.
【0081】〈乳剤G〉 (超薄平板状粒子+表面還元増感 比較例)下記のよう
に変更した以外は乳剤Bと同様にして調製した。<Emulsion G> (Ultra-thin tabular grains + surface reduction sensitization Comparative Example) Emulsion B was prepared in the same manner as Emulsion B, except for the following changes.
【0082】粒子形成終了後、二酸化チオ尿素を銀1m
ol当たり1×10-5mol添加した。After the completion of grain formation, thiourea dioxide was added to 1 m of silver.
1 × 10 −5 mol was added per ol.
【0083】〈乳剤H〉 (超薄平板状粒子+表面還元増感+チオスルホン酸ナト
リウム添加 比較例)下記のように変更した以外は乳剤
Bと同様にして調製した。<Emulsion H> (Ultra-thin tabular grains + surface reduction sensitization + addition of sodium thiosulfonate Comparative Example) Emulsion H was prepared in the same manner as Emulsion B except that the following changes were made.
【0084】粒子形成終了後、二酸化チオ尿素を銀1m
ol当たり1×10-5mol、エチルチオスルホン酸ナ
トリウムを銀1mol当たり3×10-5mol添加し
た。After the completion of grain formation, thiourea dioxide was added to 1 m of silver.
1 × 10 −5 mol per mol and sodium ethylthiosulfonate were added at 3 × 10 −5 mol per mol of silver.
【0085】〈乳剤I〉 (超薄平板状粒子+内部還元増感 比較例)下記のよう
に変更した以外は乳剤Bと同様にして調製した。<Emulsion I> (Ultra-thin tabular grains + internal reduction sensitization Comparative Example) Emulsion I was prepared in the same manner as Emulsion B except for the following changes.
【0086】核形成から24.5分後、二酸化チオ尿素
を銀1mol当たり1×10-5mol添加した。24.5 minutes after the nucleation, 1 × 10 −5 mol of thiourea dioxide was added per 1 mol of silver.
【0087】〈乳剤J〉 (超薄平板状粒子+内部還元増感1+チオスルホン酸ナ
トリウム添加 本発明)下記のように変更した以外は乳
剤Bと同様にして調製した。<Emulsion J> (Ultra-thin tabular grains + internal reduction sensitization 1 + addition of sodium thiosulfonate) This was prepared in the same manner as Emulsion B, except that the following changes were made.
【0088】核形成から24.5分後、二酸化チオ尿素
を銀1mol当たり1×10-5mol添加し、添加銀量
の80%消費した段階で、エチルチオスルホン酸ナトリ
ウムを銀1mol当たり3×10-5mol添加した。After 24.5 minutes from the nucleation, 1 × 10 −5 mol of thiourea dioxide was added per 1 mol of silver, and at the stage when 80% of the added silver was consumed, sodium ethylthiosulfonate was added at 3 × 10 5 mol per 1 mol of silver. 10 -5 mol was added.
【0089】〈乳剤K〉 (超薄平板状粒子+内部還元増感2+チオスルホン酸ナ
トリウム添加 本発明)下記のように変更した以外は乳
剤Bと同様にして調製した。<Emulsion K> (Ultra-thin tabular grains + internal reduction sensitization 2 + addition of sodium thiosulfonate) This was prepared in the same manner as Emulsion B, except that the following changes were made.
【0090】核形成から24.5分後、二酸化チオ尿素
を銀1mol当たり5×10-6mol添加し、添加銀量
の80%消費した段階で、エチルチオスルホン酸ナトリ
ウムを銀1mol当たり3×10-5mol添加した。After 24.5 minutes from the nucleation, 5 × 10 −6 mol of thiourea dioxide was added per 1 mol of silver, and at the stage when 80% of the added silver was consumed, sodium ethylthiosulfonate was added at 3 × 10 −6 mol per mol of silver. 10 -5 mol was added.
【0091】〈乳剤L〉 (超薄平板状粒子+内部還元増感1+チオスルホン酸ナ
トリウム添加 本発明)下記のように変更した以外は乳
剤Bと同様にして調製した。<Emulsion L> (Ultra-thin tabular grains + internal reduction sensitization 1 + addition of sodium thiosulfonate) In the present invention, emulsion E was prepared in the same manner as emulsion B except that the following changes were made.
【0092】核形成から24.5分後、二酸化チオ尿素
を銀1mol当たり1×10-5mol添加し、添加銀量
の80%消費した段階で、ベンゼンチオスルホン酸ナト
リウムを銀1mol当たり3×10-5mol添加した。24.5 minutes after the nucleation, 1 × 10 −5 mol of thiourea dioxide was added per 1 mol of silver, and at the stage when 80% of the added silver was consumed, sodium benzenethiosulfonate was added at 3 × 10 5 mol per 1 mol of silver. 10 -5 mol was added.
【0093】〈乳剤M〉 (超薄平板状粒子+内部還元増感2+チオスルホン酸ナ
トリウム添加 本発明)下記のように変更した以外は乳
剤Bと同様にして調製した。<Emulsion M> (Ultra-thin tabular grains + internal reduction sensitization 2 + addition of sodium thiosulfonate) In the present invention, emulsion E was prepared in the same manner as in emulsion B except that the following changes were made.
【0094】核形成から24.5分後、二酸化チオ尿素
を銀1mol当たり5×10-6mol添加し、添加銀量
の80%消費した段階で、ベンゼンチオスルホン酸ナト
リウムを銀1mol当たり3×10-5mol添加した。24.5 minutes after the nucleation, thiourea dioxide was added in an amount of 5 × 10 −6 mol per mol of silver, and sodium benzenethiosulfonate was added in an amount of 3 × 10 6 mol per mol of silver at the stage when 80% of the added silver was consumed. 10 -5 mol was added.
【0095】上記乳剤C〜Mの平均円相当径、平均厚さ
を乳剤A同様に求め、測定結果を表2に示した。The average equivalent circle diameter and average thickness of the above emulsions C to M were determined in the same manner as for emulsion A. The measurement results are shown in Table 2.
【0096】〈増感工程〉次に、上記のようにして得ら
れた乳剤A〜Mそれぞれに、次に示す増感を施した。<Sensitization step> Next, each of the emulsions A to M obtained as described above was subjected to the following sensitization.
【0097】各乳剤0.5モルを40℃で溶融し、Ag
NO3溶液とKI溶液を同時添加することによりpBr
を約4に調整した。このとき、AgNO3溶液とKI溶
液は、この調整中に少量沈殿するハロゲン化銀が12%
AgIであるような比で添加した。次に、分光増感色素
1及び2を合計被覆率が約70%になるように1:1の
割合で添加した。その後、チオシアン酸カリウム、チオ
硫酸ナトリウム、塩化金酸カリウムを添加して最適に化
学増感を施した後、4−ヒドロキシ−6−メチル−1,
3,3a,7−テトラアザインデン(TAI)、1−フ
ェニル−5−メルカプトテトラゾール(PMT)を添加
した。全ての成分を添加後、混合物を60℃に加熱して
増感を完了させ、冷却後、更にPMTを添加した。0.5 mol of each emulsion was melted at 40 ° C.
By simultaneously adding the NO 3 solution and the KI solution, pBr
Was adjusted to about 4. At this time, the AgNO 3 solution and the KI solution contained 12% of silver halide precipitated in a small amount during this preparation.
AgI was added in such a ratio as to be AgI. Next, spectral sensitizing dyes 1 and 2 were added at a ratio of 1: 1 so that the total coverage was about 70%. Thereafter, potassium thiocyanate, sodium thiosulfate and potassium chloroaurate were added to perform optimal chemical sensitization, and then 4-hydroxy-6-methyl-1,
3,3a, 7-Tetraazaindene (TAI) and 1-phenyl-5-mercaptotetrazole (PMT) were added. After all the components were added, the mixture was heated to 60 ° C. to complete the sensitization, and after cooling, more PMT was added.
【0098】[0098]
【化9】 Embedded image
【0099】〈単層感光材料作製〉増感が施された乳剤
A〜Mを、灰色銀ハレーション防止層で被覆した酢酸セ
ルロースフィルム支持体にそれぞれ塗布し、この乳剤層
を、界面活性剤とビス(ビニルスルホニル)メタン硬膜
剤(ゼラチン総重量に対して1.75重量%)とを含有
する4.3g/m2ゼラチン層でオーバーコートした。
乳剤塗布量は0.646gAg/m2であり、この層に
は、カプラー1及び2、界面活性剤及びゼラチン総量
1.08g/m2も含有させた。このようにして、乳剤
A〜Mに対してそれぞれ単層感光材料の試料101〜1
13を得た。<Preparation of Single Layer Photosensitive Material> Each of the sensitized emulsions A to M was applied to a cellulose acetate film support coated with a gray silver antihalation layer, and the emulsion layer was coated with a surfactant and bismuth. It was overcoated with a 4.3 g / m 2 gelatin layer containing (vinylsulfonyl) methane hardener (1.75% by weight based on total weight of gelatin).
The emulsion coverage was 0.646 gAg / m 2 , and this layer also contained couplers 1 and 2, a surfactant, and a total of 1.08 g / m 2 of gelatin. Thus, the samples 101 to 1 of the single-layer light-sensitive material were respectively applied to the emulsions A to M
13 was obtained.
【0100】[0100]
【化10】 Embedded image
【0101】このようにして得られた試料101〜11
3を、それぞれ白色光にて0.01秒ウェッジ露光し、
以下の処理工程に従って発色現像した。Samples 101 to 11 thus obtained
3 were each exposed to a wedge for 0.01 second with white light,
Color development was performed according to the following processing steps.
【0102】処理工程Processing steps
【0103】[0103]
【表1】 [Table 1]
【0104】発色現像、漂白液、定着液、安定液は、以
下のものを使用した。The following were used for color development, bleaching solution, fixing solution and stabilizing solution.
【0105】 (発色現像) 水 800ml 炭酸カリウム 30g 炭酸水素ナトリウム 2.5g 亜硫酸カリウム 3.0g 臭化ナトリウム 1.3g 沃化カリウム 1.2mg ヒドロキシルアミン硫酸塩 2.5g 塩化ナトリウム 0.6g 4−アミノ−3−メチル−N−エチル−N−(β−ヒドロキシルエチル) アニリン硫酸塩 4.5g ジエチレントリアミン五酢酸 3.0g 水酸化カリウム 1.2g 水を加えて1リットルとし、水酸化カリウム又は20%
硫酸を用いてpH10.06に調整する。(Color development) Water 800 ml Potassium carbonate 30 g Sodium hydrogen carbonate 2.5 g Potassium sulfite 3.0 g Sodium bromide 1.3 g Potassium iodide 1.2 mg Hydroxylamine sulfate 2.5 g Sodium chloride 0.6 g 4-amino -3-Methyl-N-ethyl-N- (β-hydroxylethyl) aniline sulfate 4.5 g Diethylenetriaminepentaacetic acid 3.0 g Potassium hydroxide 1.2 g Add water to make 1 liter, and add potassium hydroxide or 20%
Adjust to pH 10.06 with sulfuric acid.
【0106】 (漂白液) 水 700ml 1,3ジアミノプロパン四酢酸鉄(III)アンモニウム 125g エチレンジアミン四酢酸 2.0g 硝酸ナトリウム 40g 臭化アンモニウム 150g 氷酢酸 40g 水を加えて1リットルとし、アンモニア水又は氷酢酸を
用いてpH4.4に調整する。(Bleaching solution) Water 700 ml 1,3 Diaminopropanetetraacetate iron (III) ammonium 125 g ethylenediaminetetraacetic acid 2.0 g sodium nitrate 40 g ammonium bromide 150 g glacial acetic acid 40 g Add water to make 1 liter, and add ammonia water or ice Adjust to pH 4.4 with acetic acid.
【0107】 (定着液) 水 800ml チオシアン酸アンモニウム 120g チオ硫酸アンモニウム 150g 亜硫酸ナトリウム 15g エチレンジアミン四酢酸 2g 水を加えて1リットルとし、アンモニア水又は氷酢酸を
用いてpH6.2に調整する。(Fixing solution) Water 800 ml Ammonium thiocyanate 120 g Ammonium thiosulfate 150 g Sodium sulfite 15 g Ethylenediaminetetraacetic acid 2 g Water is added to make 1 liter, and the pH is adjusted to 6.2 using aqueous ammonia or glacial acetic acid.
【0108】 (安定液) 水 900ml ジメチロール尿素 0.5g ヘキサメチレンテトラミン 0.2g 1,2−ベンズイソチアゾリン−3−オン 0.1g シロキサン(UCC製 L−77) 0.1g アンモニア水 0.5ml(Stabilizing solution) Water 900 ml Dimethylolurea 0.5 g Hexamethylenetetramine 0.2 g 1,2-Benzisothiazolin-3-one 0.1 g Siloxane (UCC L-77) 0.1 g Ammonia water 0.5 ml
【0109】[0109]
【化11】 Embedded image
【0110】水を加えて1リットルとし、アンモニア水
又は50%硫酸を用いてpH8.5に調整する。Water is added to 1 liter, and the pH is adjusted to 8.5 using aqueous ammonia or 50% sulfuric acid.
【0111】その後、光学濃度計(コニカ製PDA−6
5型)を用いて感度及びカブリを測定した。Thereafter, an optical densitometer (PDA-6 manufactured by Konica) was used.
5) was used to measure the sensitivity and fog.
【0112】(評価) −感度− カブリ+0.2の濃度を与える露光量E(Eは単位;ル
クス・秒で表す)の逆数の対数の相対値で表した。(Evaluation) -Sensitivity- Fog was expressed as a relative value of the logarithm of the reciprocal of the exposure amount E (E is expressed in units of lux seconds) giving a density of +0.2.
【0113】−カブリ− カブリは未露光部での光学絶対濃度で表した。-Fog- Fog was represented by the absolute optical density of the unexposed area.
【0114】−鮮鋭性− MTF(モデュレーション・トランスファー・ファンク
ション)法により求めた。この詳細は、「写真の化学」
(写真工業出版社、笹井明著)430〜437ページに
記載されており、白色光でMTFチャートを露光現像
し、15サイクル/mmにおけるMTF値を測定した。-Sharpness- The sharpness was determined by the MTF (Modulation Transfer Function) method. For more information on this, see "Photochemistry"
(Photo Industry Publishing Co., Akira Sasai) pp. 430-437. The MTF chart was exposed and developed with white light, and the MTF value at 15 cycles / mm was measured.
【0115】試料101の感度を100としたときのそ
れぞれの相対感度、カブリ及びMTF値を表2に示す。Table 2 shows the relative sensitivity, fog, and MTF value when the sensitivity of Sample 101 was set to 100.
【0116】[0116]
【表2】 [Table 2]
【0117】※:チオスルホン酸誘導体 表2の結果から明らかなように、ブルー記録の場合、本
発明の超薄平板状粒子(乳剤J〜M)を用いた試料11
0〜113(内部還元増感に一般式で表されるチオスル
ホン酸ナトリウムを添加)は感度、カブリ及び鮮鋭性が
飛躍的に向上しているが、比較例は感度ロスが生じた
り、又表面に還元増感を施したハロゲン化銀含有の乳剤
はカブリが著しく劣化していることがわかる。総じて、
本発明により、従来に無い高感度を有し、低カブリかつ
高鮮鋭な乳剤を得ることができる。*: Thiosulfonic acid derivative As is clear from the results in Table 2, in the case of blue recording, Sample 11 using ultrathin tabular grains (Emulsions J to M) of the present invention was used.
The sensitivity, fogging and sharpness of Dramatically improved sensitization, fogging and sharpness were significantly improved in the case of 0 to 113 (addition of sodium thiosulfonate represented by the general formula for internal reduction sensitization). It can be seen that the reduction-sensitized silver halide-containing emulsion is significantly deteriorated in fog. In general,
According to the present invention, an emulsion having high sensitivity, low fog and high sharpness can be obtained.
【0118】実施例2 以下のようにして乳剤N及びOを作製した。Example 2 Emulsions N and O were prepared as follows.
【0119】〈乳剤N〉 (超薄平板状粒子+内部還元増感1+チオスルホン酸ナ
トリウム添加+メタルドーピング 本発明)下記のよう
に変更した以外は乳剤Jと同様にして調製した。<Emulsion N> (Ultra-thin tabular grains + Internal reduction sensitization 1 + Addition of sodium thiosulfonate + Metal doping) Emulsion N was prepared in the same manner as Emulsion J, except for the following changes.
【0120】核形成から24.5分後、K4Ru(C
N)6を銀1mol当たり1×10-4mol添加した。24.5 minutes after nucleation, K 4 Ru (C
N) 6 was added at 1 × 10 −4 mol per mol of silver.
【0121】〈乳剤O〉 (超薄平板状粒子+内部還元増感1+チオスルホン酸ナ
トリウム添加+メタルドーピング 本発明)下記のよう
に変更した以外は乳剤Jと同様にして調製した。<Emulsion O> (Ultra-thin tabular grains + internal reduction sensitization 1 + addition of sodium thiosulfonate + metal doping In the present invention) Emulsion O was prepared in the same manner as Emulsion J, except for the following changes.
【0122】核形成から24.5分後、K4Fe(C
N)6を銀1mol当たり1×10-4mol添加した。24.5 minutes after nucleation, K 4 Fe (C
N) 6 was added at 1 × 10 −4 mol per mol of silver.
【0123】〈増感、単層感光材料の試料作製及びその
評価〉上記のようにして得られた乳剤N及びOについて
実施例1と同様に増感を施し、そして単層感光材料を作
製し、試料21及び22を得た。このようにして得られ
た試料21及び22について、実施例1と同様に感度、
カブリ及び鮮鋭性(MTF値)を測定した。尚、実施例
1で作製した試料110の感度を100としたときのそ
れぞれの相対感度、カブリ及びMTF値を表3に示す。<Sensitization, Preparation of Sample of Single Layer Photosensitive Material and Its Evaluation> Emulsions N and O obtained as described above were sensitized in the same manner as in Example 1, and a single layer photosensitive material was prepared. And samples 21 and 22 were obtained. With respect to the samples 21 and 22 thus obtained, the sensitivity,
Fog and sharpness (MTF value) were measured. Table 3 shows the relative sensitivity, fog, and MTF value when the sensitivity of the sample 110 manufactured in Example 1 was set to 100.
【0124】[0124]
【表3】 [Table 3]
【0125】※:チオスルホン酸誘導体 表3から明らかなように、内部還元増感に一般式で表さ
れるチオスルホン酸ナトリウムを添加した超薄平板状粒
子に更にメタルをドーピングが施された本発明の試料2
1及び22は、カブリ、鮮鋭性を劣化させることなく高
感度を達成してることがわかる。上記より、メタルドー
ピングが施されることにより、従来に無い高感度を有
し、低カブリでかつ高鮮鋭な乳剤を得ることができる。*: Thiosulfonic acid derivative As is apparent from Table 3, ultrathin tabular grains to which sodium thiosulfonate represented by the general formula was added for internal reduction sensitization were further doped with a metal according to the present invention. Sample 2
It can be seen that Nos. 1 and 22 achieve high sensitivity without deteriorating fog and sharpness. As described above, by performing metal doping, it is possible to obtain an emulsion having high sensitivity, low fog, and high sharpness, which has not been achieved in the past.
【0126】実施例3 〈乳剤P〜S〉上記乳剤J、L、N、Oに、次に示すよ
うに銀塩エピタキシャルを含む増感を施し、それぞれ乳
剤P〜Sとした。Example 3 <Emulsions PS> The above emulsions J, L, N, and O were sensitized including silver salt epitaxial as shown below to obtain emulsions PS.
【0127】(エピタキシャル増感)各乳剤0.5モル
を40℃で溶融し、AgNO3溶液とKI溶液を同時添
加することによりpBrを約4に調製した。このとき、
AgNO3溶液とKI溶液は、この調製中に少量沈殿す
るハロゲン化銀が12%AgIであるような比で添加し
た。次に、2M%NaCl(ヨウ臭化銀ホストの最初の
量を基準として)を添加後、分光増感色素1及び2を合
計被覆率が約70%になるように1:1の割合で添加
し、その後、AgNO3溶液とNaCl溶液のバランス
をとったダブルジェット添加により6M%AgClエピ
タキシーを形成させた。この操作により、エピタキシー
成長が、ホスト平板粒子の主としてコーナーとエッジに
生じた。続いて分光増感色素1及び2を追加して最適に
分光増感を施した。これより後は実施例1と同様に、チ
オシアン酸カリウム、チオ硫酸ナトリウム、塩化金酸カ
リウムを添加して最適に化学増感を施した後、上記TA
I及びPMTを添加した。全ての成分を添加後、混合物
を60℃に加熱して増感を完了させ、冷却後、更にPM
Tを添加した。(Epitaxial Sensitization) 0.5 mol of each emulsion was melted at 40 ° C., and pBr was adjusted to about 4 by simultaneously adding an AgNO 3 solution and a KI solution. At this time,
The AgNO 3 solution and the KI solution were added at a ratio such that the silver halide that precipitated in small amounts during this preparation was 12% AgI. Next, after addition of 2M% NaCl (based on the initial amount of silver iodobromide host), spectral sensitizing dyes 1 and 2 were added in a 1: 1 ratio so that the total coverage was about 70%. Thereafter, 6M% AgCl epitaxy was formed by double jet addition, which balanced the AgNO 3 solution and the NaCl solution. This operation resulted in epitaxy growth mainly at the corners and edges of the host tabular grains. Subsequently, spectral sensitizing dyes 1 and 2 were added for optimal spectral sensitization. Thereafter, as in Example 1, potassium thiocyanate, sodium thiosulfate, and potassium chloroaurate were added to perform optimal chemical sensitization, and then the above TA
I and PMT were added. After all the components have been added, the mixture is heated to 60 ° C. to complete the sensitization, and after cooling,
T was added.
【0128】〈単層感光材料の試料作製及びその評価〉
次に、上記エピタキシャル増感が施された乳剤P〜Sを
使用して実施例1と同様に単層感光材料の試料を作製
し、乳剤P〜Sに対してそれぞれ試料31〜34を得
た。<Preparation of Sample of Single Layer Photosensitive Material and Its Evaluation>
Next, samples of the single-layer light-sensitive material were prepared in the same manner as in Example 1 using the emulsions P to S subjected to the epitaxial sensitization, and samples 31 to 34 were obtained for the emulsions P to S, respectively. .
【0129】このようにして得られた試料31〜34に
ついて、実施例1と同様に感度、カブリ及び鮮鋭性(M
TF値)を測定した。実施例1で作製した試料110の
感度を100としたときのそれぞれの相対感度、カブリ
及びMTF値を以下の表4に示す。For the samples 31 to 34 thus obtained, the sensitivity, fog and sharpness (M
TF value) was measured. Table 4 below shows the relative sensitivity, fog, and MTF value of the sample 110 manufactured in Example 1 assuming that the sensitivity is 100.
【0130】[0130]
【表4】 [Table 4]
【0131】※:チオスルホン酸誘導体 表4から明らかなように、本発明の乳剤は、内部還元増
感にチオスルホン酸ナトリウムを添加した超薄平板状粒
子にエピタキシャルを含む増感を施すことによって、鮮
鋭度は若干劣化するものの、カブリを劣化させることな
く感度が著しく増加していることがわかり、それにより
従来に無い高感度を有し、かつ低カブリでかつ高鮮鋭な
乳剤を得ることができる。*: Thiosulfonic acid derivative As can be seen from Table 4, the emulsion of the present invention is sharpened by subjecting ultrathin tabular grains to which sodium thiosulfonate is added for internal reduction sensitization to sensitization including epitaxial growth. Although the degree is slightly deteriorated, it is found that the sensitivity is remarkably increased without deteriorating the fog, whereby it is possible to obtain an emulsion having a high sensitivity, low fog, and high sharpness which has not been obtained conventionally.
【0132】実施例4 次にマイナスブルー記録に本発明を適用した実施例を記
す。Embodiment 4 Next, an embodiment in which the present invention is applied to minus blue recording will be described.
【0133】実施例1の増感工程において、分光増感色
素を以下に示す3〜5に変更し、該分光増感色素3〜5
を合計被覆率が約70%になるように1:1:1の割合
で添加し、又単層感光材料の試料作製でカプラーを以下
に示すカプラー3及び4に変えた以外は実施例1と同様
にして得られた乳剤を使用して増感を施し、単層感光材
料の試料401〜413を得、同様に処理(但し、発色
現像時間は2分50秒)及び評価を行った。得られた結
果を表5に示す。In the sensitizing step of Example 1, the spectral sensitizing dyes were changed to the following 3 to 5 and the spectral sensitizing dyes 3 to 5 were changed.
Was added at a ratio of 1: 1: 1 so that the total coverage was about 70%, and the couplers were changed to couplers 3 and 4 shown below in the preparation of a single-layer light-sensitive material. The emulsion obtained in the same manner was sensitized to obtain samples 401 to 413 of single-layered light-sensitive materials, which were similarly processed (however, the color development time was 2 minutes and 50 seconds) and evaluated. Table 5 shows the obtained results.
【0134】[0134]
【化12】 Embedded image
【0135】[0135]
【化13】 Embedded image
【0136】[0136]
【表5】 [Table 5]
【0137】※:チオスルホン酸誘導体 表5から明らかなように、本発明の乳剤をマイナスブル
ー記録に適用した場合でもブルー記録の場合と同様な改
良効果が確認された。*: Thiosulfonic acid derivative As is apparent from Table 5, the same improvement effect as in the case of blue recording was confirmed when the emulsion of the present invention was applied to minus blue recording.
【0138】実施例5 実施例2の増感工程で、分光増感色素を上記分光増感色
素3〜5に変更し、該分光増感色素3〜5を合計被覆率
が約70%になるように1:1:1の割合で添加し、又
単層感光材料の試料作製でカプラーを上記カプラー3及
び4に変えた以外は実施例2と同様にして得られた乳剤
を使用して増感を施し、単層感光材料の試料51〜52
を得、同様に処理(但し、発色現像時間は2分50秒)
及び評価を行った。得られた結果を表6に示す。Example 5 In the sensitization step of Example 2, the spectral sensitizing dyes were changed to the above-mentioned spectral sensitizing dyes 3 to 5, and the total coverage of the spectral sensitizing dyes 3 to 5 became about 70%. As described above, the emulsion was added in the ratio of 1: 1: 1, and the emulsion was obtained in the same manner as in Example 2 except that the couplers were changed to the above couplers 3 and 4 in the preparation of a sample of a single-layer photosensitive material. Sensation, samples 51 to 52 of the single-layer photosensitive material
And processed in the same way (however, the color development time is 2 minutes and 50 seconds)
And evaluation. Table 6 shows the obtained results.
【0139】[0139]
【表6】 [Table 6]
【0140】※:チオスルホン酸誘導体 表6から明らかなように、本発明の乳剤をマイナスブル
ー記録に適用した場合でもブルー記録の場合と同様な改
良効果が確認された。*: Thiosulfonic acid derivative As is clear from Table 6, when the emulsion of the present invention was applied to minus blue recording, the same improvement effect as in blue recording was confirmed.
【0141】実施例6 実施例3の増感工程で、分光増感色素を上記分光増感色
素3〜5に変更し、該分光増感色素3〜5を合計被覆率
が約70%になるように1:1:1の割合で添加し、又
単層感光材料の試料作製でカプラーを上記カプラー3及
び4に変えた以外は実施例3と同様にして得られた乳剤
を使用して増感を施し、単層感光材料の試料61〜64
を得、同様に処理(但し、発色現像時間は2分50秒)
及び評価を行った。得られた結果を表7に示す。Example 6 In the sensitization step of Example 3, the spectral sensitizing dye was changed to the above-mentioned spectral sensitizing dyes 3 to 5, and the total coverage of the spectral sensitizing dyes 3 to 5 became about 70%. 1: 1: 1 as described above, and using the emulsion obtained in the same manner as in Example 3 except that the couplers were changed to the above couplers 3 and 4 in the preparation of a sample of a single layer photosensitive material. Sensation, and samples 61 to 64 of single-layer photosensitive material
And processed in the same way (however, the color development time is 2 minutes and 50 seconds)
And evaluation. Table 7 shows the obtained results.
【0142】[0142]
【表7】 [Table 7]
【0143】※:チオスルホン酸誘導体 表7から明らかなように、本発明の乳剤をマイナスブル
ー記録に適用した場合でもブルー記録の場合と同様な改
良効果が確認された。*: Thiosulfonic acid derivative As is clear from Table 7, even when the emulsion of the present invention was applied to minus blue recording, the same improvement effect as in the case of blue recording was confirmed.
【0144】尚、本発明のこれらの超薄平板状粒子を多
層写真感材に適用した場合でも、同様の効果を表した。The same effect was obtained when these ultrathin tabular grains of the present invention were applied to a multilayer photographic light-sensitive material.
【0145】[0145]
【発明の効果】本発明により、ブルー記録及びマイナス
ブルー記録においても高感度かつ低カブリ、更に鮮鋭性
に優れた超薄平板状ハロゲン化銀写真乳剤が得られると
いう顕著に優れた効果を奏する。According to the present invention, an extremely thin tabular silver halide photographic emulsion having high sensitivity, low fog and excellent sharpness can be obtained even in blue recording and minus blue recording.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 FI G03C 1/09 G03C 1/09 ──────────────────────────────────────────────────続 き Continued on front page (51) Int.Cl. 6 Identification code FI G03C 1/09 G03C 1/09
Claims (4)
率が70mol%以上、平均円相当径が0.7μm以上
であり、かつ平均粒子厚さが0.07μm未満の平板状
ハロゲン化銀粒子が全投影面積の90%以上を占めるハ
ロゲン化銀乳剤であって、その製造工程中に、前記平板
状ハロゲン化銀粒子内部に還元増感を施こし、かつ下記
一般式(1)乃至(3)で表される化合物から選ばれる
少なくとも1種を添加された乳剤であることを特徴とす
るハロゲン化銀乳剤。 一般式 (1) R−SO2S−M (2) R−SO2S−R1 (3) R−SO2S−Lm−SSO2−R2 (式中、R、R1、R2は脂肪族基、脂環式(化合物残)
基、芳香族基或いはヘテロ環基を表し、各々同一でも異
なってもよく、又Mは陽イオンを表す。Lは二価の連結
基を表し、mは0又は1である。上記一般式(1)乃至
(3)の化合物は、該(1)乃至(3)で示す構造から
誘導される2価の基を繰り返し単位として含有するポリ
マーであっても良い。又可能なときはR、R1、R2、L
が互いに結合して環を形成しても良い。)1. A flat plate having a (111) main surface, an average silver bromide content of 70 mol% or more, an average equivalent circle diameter of 0.7 μm or more, and an average grain thickness of less than 0.07 μm. A silver halide emulsion in which silver halide grains occupy 90% or more of the total projected area, wherein reduction sensitization is performed inside the tabular silver halide grains during the production process, and the following general formula (1) A) a silver halide emulsion, which is an emulsion to which at least one selected from the compounds represented by (3) is added. Formula (1) R-SO 2 S -M (2) R-SO 2 S-R 1 (3) in R-SO 2 S-L m -SSO 2 -R 2 ( wherein, R, R 1, R 2 is an aliphatic group, alicyclic (remaining compound)
Represents an aromatic group or a heterocyclic group, which may be the same or different, and M represents a cation. L represents a divalent linking group, and m is 0 or 1. The compounds of the above general formulas (1) to (3) may be polymers containing, as a repeating unit, a divalent group derived from the structure shown in the above (1) to (3). When possible, R, R 1 , R 2 , L
May combine with each other to form a ring. )
トを含むことを特徴とする請求項1記載のハロゲン化銀
乳剤。2. The silver halide emulsion according to claim 1, wherein said tabular silver halide grains contain a dopant.
性化学増感部位を有し、該部位がエピタキシャル配置さ
れた少なくとも1種のハロゲン化銀突起部を含むことを
特徴とする請求項1又は2記載のハロゲン化銀乳剤。3. The silver halide grain has a latent image forming chemical sensitized site on its surface, and the site includes at least one type of silver halide projection portion epitaxially arranged. 3. The silver halide emulsion according to 1 or 2.
ゲン化銀乳剤を含むことを特徴とする写真感光材料。4. A photographic light-sensitive material comprising the silver halide emulsion according to claim 1.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP03721698A JP3687326B2 (en) | 1997-02-19 | 1998-02-19 | Silver halide emulsion and photographic light-sensitive material using the same |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9-34996 | 1997-02-19 | ||
| JP3499697 | 1997-02-19 | ||
| JP03721698A JP3687326B2 (en) | 1997-02-19 | 1998-02-19 | Silver halide emulsion and photographic light-sensitive material using the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH10293376A true JPH10293376A (en) | 1998-11-04 |
| JP3687326B2 JP3687326B2 (en) | 2005-08-24 |
Family
ID=26373877
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP03721698A Expired - Fee Related JP3687326B2 (en) | 1997-02-19 | 1998-02-19 | Silver halide emulsion and photographic light-sensitive material using the same |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3687326B2 (en) |
-
1998
- 1998-02-19 JP JP03721698A patent/JP3687326B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP3687326B2 (en) | 2005-08-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0699951B1 (en) | Ultrathin tabular grain emulsions with novel dopant management | |
| US5726005A (en) | Photographic print elements containing cubical grain silver iodochloride emulsions | |
| US5547827A (en) | Iodochloride emulsions containing quinones having high sensitivity and low fog | |
| US5550013A (en) | High chloride emulsions having high sensitivity and low fog and improved photographic responses of HIRF, higher gamma, and shoulder density | |
| US5605789A (en) | Iodochloride emulsions containing iodonium salts having high sensitivity and low fog | |
| US5582965A (en) | Ultrathin tabular grain emulsions with sensitization enhancements (II) | |
| US5728516A (en) | Photographic print elements containing cubical grain silver iodochloride emulsions | |
| JP2000180999A (en) | Photographic element | |
| US5631126A (en) | Epitaxially sensitized tabular grain emulsions containing speed/fog sulfodihydroxy aryl enhancing addenda | |
| US5629144A (en) | Epitaxially sensitized tabular grain emulsions containing speed/fog mercaptotetrazole enhancing addenda | |
| US5573902A (en) | Tabular grain emulsions with sensitization enhancements | |
| EP0699946B1 (en) | Ultrathin tabular grain emulsions with sensitization enhancements (II) | |
| JP3687326B2 (en) | Silver halide emulsion and photographic light-sensitive material using the same | |
| US6740482B1 (en) | High chloride emulsion having high sensitivity and low fog | |
| JPH08339047A (en) | Photographic element | |
| EP0699944B1 (en) | Tabular grain emulsions with sensitization enhancements | |
| JPH08171163A (en) | Radiation-sensitive emulsion and photographic element | |
| JPH08101473A (en) | Radiation-sensitive emulsion and photographic element | |
| JP4221860B2 (en) | Silver halide emulsion and silver halide photographic light-sensitive material | |
| JPH08101472A (en) | Radiation-sensitive emulsion and photographic element | |
| JPH10228069A (en) | Silver halide photographic emulsion and photographic sensitive material | |
| JPH09197610A (en) | Halogenated silver photographic emulsion and halogenated silver color photographic photographic material using this emulsion | |
| JPH09160151A (en) | Silver halide emulsion, its manufacture, and silver halide color photographic sensitive material using same | |
| JPH1184558A (en) | Silver halide photographic emulsion | |
| JPH11160824A (en) | Silver halide photographic emulsion |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20040813 |
|
| A131 | Notification of reasons for refusal |
Effective date: 20040824 Free format text: JAPANESE INTERMEDIATE CODE: A131 |
|
| A131 | Notification of reasons for refusal |
Effective date: 20050125 Free format text: JAPANESE INTERMEDIATE CODE: A131 |
|
| A521 | Written amendment |
Effective date: 20050324 Free format text: JAPANESE INTERMEDIATE CODE: A523 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20050517 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20050530 |
|
| R150 | Certificate of patent (=grant) or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| LAPS | Cancellation because of no payment of annual fees |